Riversource Life Insurance 10-Q 2 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 02, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	033-28976
Entity Registrant Name	RIVERSOURCE LIFE INSURANCE COMPANY
Entity Incorporation, State or Country Code	MN
Entity Tax Identification Number	41-0823832
Entity Address, Address Line One	1099 Ameriprise Financial Center
Entity Address, City or Town	Minneapolis
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55474
City Area Code	(612)
Local Phone Number	671-3131
Title of 12(b) Security	Common Stock (par value $30 per share)
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		100,000
Entity Central Index Key	0000727892
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
No Trading Symbol Flag	true

CONSOLIDATED BALANCE SHEETS (UN

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Investments:
Reinsurance recoverables (allowance for credit losses: 2022, $18; 2021, $11)	$ 4,422	$ 4,529
Deferred acquisition costs	2,980	2,757
Separate account assets	68,177	92,238
Total assets	111,971	139,496
Liabilities:
Policyholder account balances, future policy benefits and claims	35,475	35,744
Short-term borrowings	201	200
Separate account liabilities	68,177	92,238
Total liabilities	111,385	137,611
Shareholder’s equity:
Common stock, $30 par value; 100,000 shares authorized, issued and outstanding	3	3
Additional paid-in capital	2,466	2,466
Accumulated deficit	(817)	(912)
Accumulated other comprehensive income (loss), net of tax	(1,066)	328
Total shareholder’s equity	586	1,885
Total liabilities and shareholder’s equity	111,971	139,496
RiverSource Life
Investments:
Available-for-Sale: Fixed maturities, at fair value (amortized cost: 2022, $16,809; 2021, $14,718) (allowance for credit losses: 2022, $22; 2021, $1)	15,389	16,239
Mortgage loans, at amortized cost (allowance for credit losses: 2022, $11; 2021, $12)	1,804	1,788
Policy loans	838	834
Other investments (allowance for credit losses: 2022, nil; 2021, nil)	224	230
Total investments	18,255	19,091
Cash and cash equivalents	2,559	3,200
Receivables	7,794	8,148
Accrued investment income	145	124
Other assets	5,047	7,084
Liabilities:
Short-term borrowings	201	200
Long-term debt	500	500
Other liabilities	4,470	6,628
Consolidated investment entities
Investments:
Total investments	2,378	2,184
Cash and cash equivalents	174	121
Receivables	38	17
Other assets	2	3
Liabilities:
Long-term debt	2,401	2,164
Other liabilities	$ 161	$ 137

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Shareholder's equity:
Common stock, par value (in dollars per share)	$ 30	$ 30
Common stock, authorized (in shares)	100,000	100,000
Common stock, issued (in shares)	100,000	100,000
Common stock, outstanding (in shares)	100,000	100,000
RiverSource Life
Assets
Available-for-sale: Fixed maturities, amortized cost	$ 16,809	$ 14,718
Available-for-sale: Fixed maturities, allowance for credit losses	22	1
Reinsurance recoverables, allowance for credit loss	18	11
RiverSource Life | Fixed maturities
Assets
Available-for-sale: Fixed maturities, amortized cost	16,809	14,718
Available-for-sale: Fixed maturities, allowance for credit losses	22	1
RiverSource Life | Mortgages
Assets
Allowance for credit losses	11	12
RiverSource Life | Other investments
Assets
Allowance for credit losses	$ 0	$ 0

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Premiums	$ 76	$ (1,098)	$ 223	$ (945)
Net investment income	224	193	568	664
Policy and contract charges	522	590	1,626	1,715
Other revenues	155	177	492	436
Net realized investment gains (losses)	(92)	533	(90)	589
Total revenues	885	395	2,819	2,459
Benefits and expenses
Benefits, claims, losses and settlement expenses	368	(719)	660	337
Interest credited to fixed accounts	157	172	443	455
Amortization of deferred acquisition costs	104	6	343	69
Interest and debt expense	29	43	71	84
Other insurance and operating expenses	175	179	509	553
Total benefits and expenses	833	(319)	2,026	1,498
Pretax income (loss)	52	714	793	961
Income tax provision (benefit)	1	111	98	121
Net income (loss)	$ 51	$ 603	$ 695	$ 840

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 51	$ 603	$ 695	$ 840
Other comprehensive income (loss), net of tax:
Net unrealized gains (losses) on securities	(424)	(321)	(1,394)	(519)
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Total comprehensive income	$ (373)	$ 282	$ (699)	$ 321

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (UNAUDITED) - USD ($) $ in Millions	Total	Common Shares	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other  Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ 3,313	$ 3	$ 2,466	$ (76)	$ 920
Increase (Decrease) in Stockholders' Equity
Net income	840			840
Other comprehensive income (loss), net of tax	(519)				(519)
Cash dividends to Ameriprise Financial, Inc.	(1,675)			(1,675)
Ending balance at Sep. 30, 2021	1,959	3	2,466	(911)	401
Beginning balance at Jun. 30, 2021	2,602	3	2,466	(589)	722
Increase (Decrease) in Stockholders' Equity
Net income	603			603
Other comprehensive income (loss), net of tax	(321)				(321)
Cash dividends to Ameriprise Financial, Inc.	(925)			(925)
Ending balance at Sep. 30, 2021	1,959	3	2,466	(911)	401
Beginning balance at Dec. 31, 2021	1,885	3	2,466	(912)	328
Increase (Decrease) in Stockholders' Equity
Net income	695			695
Other comprehensive income (loss), net of tax	(1,394)				(1,394)
Cash dividends to Ameriprise Financial, Inc.	(600)			(600)
Ending balance at Sep. 30, 2022	586	3	2,466	(817)	(1,066)
Beginning balance at Jun. 30, 2022	1,059	3	2,466	(768)	(642)
Increase (Decrease) in Stockholders' Equity
Net income	51			51
Other comprehensive income (loss), net of tax	(424)				(424)
Cash dividends to Ameriprise Financial, Inc.	(100)			(100)
Ending balance at Sep. 30, 2022	$ 586	$ 3	$ 2,466	$ (817)	$ (1,066)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income	$ 695	$ 840
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion, net	(147)	(50)
Deferred income tax (benefit) expense	122	(43)
Contractholder and policyholder charges, non-cash	(295)	(292)
Loss from equity method investments	37	56
Net realized investment (gains) losses	(4)	(602)
Impairments and provision for loan losses	87	1
Net losses (gains) of consolidated investment entities	5	(17)
Changes in operating assets and liabilities:
Deferred acquisition costs	197	(127)
Policyholder account balances, future policy benefits and claims, net	1,049	1,465
Derivatives, net of collateral	446	(316)
Reinsurance recoverables	77	20
Receivables	213	6
Accrued investment income	(21)	16
Current income tax, net	(77)	(401)
Payable for investment securities purchase	0	20
Other operating assets and liabilities of consolidated investment entities	1	15
Other, net	21	77
Net cash provided by (used in) operating activities	2,406	668
Available-for-Sale securities:
Proceeds from sales	741	555
Maturities, sinking fund payments and calls	1,349	2,396
Purchases	(4,235)	(2,680)
Proceeds from sales, maturities and repayments of mortgage loans	93	218
Funding of mortgage loans	(109)	(152)
Proceeds from sales and collections of other investments	15	88
Purchase of other investments	(44)	(31)
Purchase of investments by consolidated investment entities	(763)	(1,461)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities	466	850
Purchase of equipment and software	(10)	(9)
Change in policy loans, net	(4)	10
Cash paid for deposit receivable	(34)	(216)
Cash received for deposit receivable	393	132
Advance on line of credit to Ameriprise Financial, Inc.	(1,034)	(1)
Repayment from Ameriprise Financial, Inc. on line of credit	1,034	1
Cash received from written options with deferred premiums	141	60
Cash paid for written options with deferred premiums	(411)	(314)
Other, net	(42)	(19)
Net cash provided by (used in) investing activities	(2,454)	(573)
Policyholder account balances:
Deposits and other additions	766	1,131
Net transfers from (to) separate accounts	(128)	(206)
Surrenders and other benefits	(989)	(1,002)
Proceeds from line of credit with Ameriprise Financial, Inc.	0	5
Payments on line of credit with Ameriprise Financial, Inc.	0	(5)
Cash received for purchased options with deferred premiums	230	580
Cash paid for purchased options with deferred premiums	(159)	(94)
Borrowings by consolidated investment entities	341	1,375
Repayments of debt by consolidated investment entities	(1)	(757)
Cash dividends to Ameriprise Financial, Inc.	(600)	(1,675)
Net cash provided by (used in) financing activities	(540)	(648)
Net increase (decrease) in cash and cash equivalents	(588)	(553)
Cash and cash equivalents at beginning of period	3,321	3,285
Cash and cash equivalents at end of period	2,733	2,732
Supplemental Disclosures:
Income taxes paid (received), net	56	567
Non-cash investing activity:
Exchange of an investment that resulted in a realized gain and an increase to amortized cost	0	17
Investments transferred in connection with reinsurance transaction	0	7,527
RiverSource Life
Supplemental Disclosures:
Interest paid	1	0
Consolidated investment entities
Supplemental Disclosures:
Interest paid	$ 49	$ 73

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation RiverSource Life Insurance Company is a stock life insurance company with one wholly owned stock life insurance company subsidiary, RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”). • RiverSource Life Insurance Company is domiciled in Minnesota and holds Certificates of Authority in American Samoa, the District of Columbia and all states except New York. RiverSource Life Insurance Company issues insurance and annuity products. • RiverSource Life of NY is domiciled and holds a Certificate of Authority in New York. RiverSource Life of NY issues insurance and annuity products. RiverSource Life Insurance Company also wholly owns RiverSource Tax Advantaged Investments, Inc. (“RTA”) and Columbia Cent CLO Advisors, LLC (“Columbia Cent”). RTA is a stock company domiciled in Delaware and is a limited partner in affordable housing partnership investments. Columbia Cent provides asset management services to collateralized loan obligations (“CLOs”). The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest and variable interest entities (“VIEs”) in which it is the primary beneficiary (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation. The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for fair statement of the consolidated financial position and results of operations for the interim periods have been made. All adjustments made were of a normal recurring nature. In the second quarter of 2022, the Company recorded an out-of-period correction of $256 million, net of tax, in other comprehensive income (“OCI”) resulting in an increase to total equity and total comprehensive income, correcting the shadow unearned revenue liability balance associated with universal life insurance products. The impact of this out-of-period adjustment was not material to any previously reported quarterly or annual financial statements and is not expected to be material to the 2022 annual financial statements. The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on February 25, 2022 (“2021 10-K”). The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. No subsequent events or transactions requiring recognition or disclosure were identified.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Future Adoption of New Accounting Standards Financial Instruments – Credit Losses – Troubled Debt Restructurings and Vintage Disclosures In March 2022, the Financial Accounting Standards Board (“FASB”) proposed amendments to Accounting Standard Update No. 2016-13, Financial Instruments—Credit Losses: Measurement of Credit Losses on Financial Instruments (“Topic 326”). The update removes the recognition and measurement guidance for Troubled Debt Restructurings (“TDRs”) by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, and modifies the disclosure requirements for certain loan refinancing and restructuring by creditors when a borrower is experiencing financial difficulty. Rather than applying the recognition and measurement for TDRs, an entity must apply the loan refinancing and restructuring guidance to determine whether a modification results in a new loan or a continuation of an existing loan. The update also requires entities to disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The amendments are to be applied prospectively, but entities may apply a modified retrospective transition for changes to the recognition and measurement of TDRs. For entities that have adopted Topic 326, the amendments are effective for interim and annual periods beginning after December 15, 2022. Early adoption is permitted for entities that have adopted Topic 326, including adoption in an interim period. The adoption of the standard is not expected to have a material impact on the Company’s consolidated financial condition and results of operations. Financial Services – Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts In August 2018, the FASB updated the accounting standard related to long-duration insurance contracts. The guidance revises elements of the measurement models and disclosure requirements for long-duration insurance contracts issued by insurers. Adoption of the accounting standard will not impact overall cash flows, insurance subsidiaries’ dividend capacity, or regulatory capital requirements. When the Company adopts the standard as of January 1, 2021 (the “transition date”), opening equity will be adjusted for the adoption impacts to retained earnings and accumulated other comprehensive income (loss) (“AOCI”) and prior periods presented (i.e. 2021 and 2022) will be restated. The Company has updated its estimated adoption impact as of January 1, 2021 to be a reduction in total equity of $1.8 billion to $2.1 billion, of which a significant portion will be reflected in AOCI. However, as of September 30, 2022, the impact on total equity is estimated to be an increase of $400 million to $600 million as a result of changes in the equity, credit, and rate environment subsequent to the transition date. The Company utilizes a governance framework to guide its adoption process and is managing a detailed implementation plan to support the timely application of the standard in the first quarter of 2023. The Company continues to refine its technology solutions and internal controls environment. These activities include, but are not limited to, modifications of actuarial valuation models, and accounting and financial reporting processes and systems. The estimated adoption impact at transition date and the impact to periods subsequent to transition date is subject to change as the Company completes its adoption process.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Policy and contract charges Affiliated $ 40 $ 50 $ 126 $ 144 Unaffiliated 3 4 11 12 Total 43 54 137 156 Other revenues Administrative fees Affiliated 10 13 32 37 Unaffiliated 5 5 14 15 15 18 46 52 Other fees Affiliated 80 99 258 291 Unaffiliated 1 1 3 4 81 100 261 295 Total 96 118 307 347 Total revenue from contracts with customers 139 172 444 503 Revenue from other sources (1) 746 223 2,375 1,956 Total revenues $ 885 $ 395 $ 2,819 $ 2,459 (1) Amounts primarily consist of revenue associated with insurance and annuity products or financial instruments. The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company’s contracts with customers. Policy and contract charges The Company earns revenue for providing distribution-related services to affiliated and unaffiliated mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company’s control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis. Other revenues Administrative fees The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds that are available as underlying instruments in its variable annuity and variable life insurance products. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis. Other fees The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, Ameriprise Financial Services, LLC (“AFS”), that sell the Company's products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company's variable annuity and variable life insurance products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis. Receivables Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $49 million and $62 million as of September 30, 2022 and December 31, 2021, respectively.

Variable Interest Entities

Variable Interest Entities	9 Months Ended
	Sep. 30, 2022
Variable Interest Entities [Abstract]
Variable Interest Entities	Variable Interest Entities The Company provides asset management services to collateralized loan obligations (“CLOs”) which are considered to be VIEs that are sponsored by the Company. In addition, the Company invests in structured investments other than CLOs and certain affordable housing partnerships which are considered VIEs. The Company consolidates the CLOs if the Company is deemed to be the primary beneficiary. The Company has no obligation to provide financial or other support to the non-consolidated VIEs beyond its initial investment and existing future funding commitments, and the Company has not provided any support to these entities. The Company has unfunded commitments related to consolidated CLOs of $28 million and $27 million as of September 30, 2022 and December 31, 2021, respectively. CLOs CLOs are asset backed financing entities collateralized by a pool of assets, primarily syndicated loans and, to a lesser extent, high-yield bonds. Multiple tranches of debt securities are issued by a CLO, offering investors various maturity and credit risk characteristics. The debt securities issued by the CLOs are non-recourse to the Company. The CLO’s debt holders have recourse only to the assets of the CLO. The assets of the CLOs cannot be used by the Company. Scheduled debt payments are based on the performance of the CLO’s collateral pool. The Company earns management fees from the CLOs based on the value of the CLO’s collateral pool and, in certain instances, may also receive incentive fees. The fee arrangement is at market and commensurate with the level of effort required to provide those services. The Company has invested in a portion of the unrated, junior subordinated notes and highly rated senior notes of certain CLOs. The Company consolidates certain CLOs where it is the primary beneficiary and has the power to direct the activities that most significantly impact the economic performance of the CLO. The Company’s maximum exposure to loss with respect to non-consolidated CLOs is limited to its amortized cost, which was $1 million as of both September 30, 2022 an d December 31, 2021. The Company classifies these investments as Available-for-Sale securities. See Note 5 for additional information on these investments. Affordable Housing Partnerships and Other Real Estate Partnerships The Company is a limited partner in affordable housing partnerships that qualify for government-sponsored low income housing tax credit programs and partnerships that invest in multi-family residential properties that were originally developed with an affordable housing component. The Company has determined it is not the primary beneficiary and therefore does not consolidate these partnerships. A majority of the limited partnerships are VIEs. The Company’s maximum exposure to loss as a result of its investment in the VIEs is limited to the carrying value. The carrying value is reflected in Other investments and was $105 million and $138 million as of September 30, 2022 and December 31, 2021, respectively. The Company has a liability of $7 million and $8 million as of September 30, 2022 and December 31, 2021, respectively, related to original purchase commitments not yet remitted to the VIEs. The Company has not provided any additional support and is not contractually obligated to provide additional support to the VIEs beyond the funding commitments. Structured Investments The Company invests in structured investments which are considered VIEs for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities, and commercial and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its amortized cost. See Note 5 for additional information on these structured investments. Fair Value of Assets and Liabilities The Company categorizes its fair value measurements according to a three-level hierarchy. See Note 11 for the definition of the three levels of the fair value hierarchy. The following tables present the balances of assets and liabilities held by consolidated investment entities measured at fair value on a recurring basis: September 30, 2022 Level 1 Level 2 Level 3 Total (in millions) Assets Investments: Corporate debt securities $ — $ 28 $ — $ 28 Common stocks — 3 — 3 Syndicated loans — 2,182 165 2,347 Total investments — 2,213 165 2,378 Receivables — 38 — 38 Other assets — 2 — 2 Total assets at fair value $ — $ 2,253 $ 165 $ 2,418 Liabilities Debt (1) $ — $ 2,401 $ — $ 2,401 Other liabilities — 161 — 161 Total liabilities at fair value $ — $ 2,562 $ — $ 2,562 December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Assets Investments: Common stocks $ — $ 3 $ — $ 3 Syndicated loans — 2,117 64 2,181 Total investments — 2,120 64 2,184 Receivables — 17 — 17 Other assets — — 3 3 Total assets at fair value $ — $ 2,137 $ 67 $ 2,204 Liabilities Debt (1) $ — $ 2,164 $ — $ 2,164 Other liabilities — 137 — 137 Total liabilities at fair value $ — $ 2,301 $ — $ 2,301 (1) The carrying value of the CLOs’ debt is set equal to the fair value of the CLOs’ assets. The estimated fair value of the CLOs’ debt was $2.4 billion and $2.2 billion as of September 30, 2022 and December 31, 2021, respectively. The following tables provide a summary of changes in Level 3 assets held by consolidated investment entities measured at fair value on a recurring basis: Common Stocks Syndicated Loans (in millions) Balance at July 1, 2022 $ 2 $ 95 Total gains (losses) included in: Net income — (4) (1) Purchases — 42 Sales — (3) Settlements — (1) Transfers into Level 3 — 61 Transfers out of Level 3 (2) (25) Balance at September 30, 2022 $ — $ 165 Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2022 $ — $ (5) (1) Syndicated Loans (in millions) Balance at July 1, 2021 $ 112 Purchases 7 Sales (4) Settlements (10) Transfers into Level 3 5 Transfers out of Level 3 (47) Deconsolidation of consolidated investment entities (18) Balance at September 30, 2021 $ 45 Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2021 $ — (1) Common Stocks Syndicated Loans Other Assets (in millions) Balance at January 1, 2022 $ — $ 64 $ 3 Total gains (losses) included in: Net income — (7) (1) — Purchases — 64 — Sales — (4) — Settlements — (8) — Transfers into Level 3 2 173 — Transfers out of Level 3 (2) (117) (3) Balance at September 30, 2022 $ — $ 165 $ — Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2022 $ — $ (5) (1) $ — Syndicated Loans Other Assets (in millions) Balance at January 1, 2021 $ 92 $ 2 Total gains (losses) included in: Net income 2 (1) — Purchases 88 — Sales (38) — Settlements (49) — Transfers into Level 3 90 — Transfers out of Level 3 (122) (2) Deconsolidation of consolidated investment entities (18) — Balance at September 30, 2021 $ 45 $ — Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2021 $ — (1) $ — (1) Included in Net investment income. Securities and loans transferred from Level 3 primarily represent assets with fair values that are now obtained from a third-party pricing service with observable inputs or priced in active markets. Securities and loans transferred to Level 3 represent assets with fair values that are now based on a single non-binding broker quote. All Level 3 measurements as of September 30, 2022 and December 31, 2021 were obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company. Determination of Fair Value Assets Investments The fair value of syndicated loans obtained from third-party pricing services using a market approach with observable inputs is classified as Level 2. The fair value of syndicated loans obtained from third-party pricing services with a single non-binding broker quote as the underlying valuation source is classified as Level 3. The underlying inputs used in non-binding broker quotes are not readily available to the Company. See Note 11 for a description of the Company’s determination of the fair value of corporate debt securities, common stocks and other investments. Receivables For receivables of the consolidated CLOs, the carrying value approximates fair value as the nature of these assets has historically been short term and the receivables have been collectible. The fair value of these receivables is classified as Level 2. Liabilities Debt The fair value of the CLOs’ assets, typically syndicated bank loans, is more observable than the fair value of the CLOs’ debt tranches for which market activity is limited and less transparent. As a result, the fair value of the CLOs’ debt is set equal to the fair value of the CLOs’ assets and is classified as Level 2. Other Liabilities Other liabilities consist primarily of securities purchased but not yet settled held by consolidated CLOs. The carrying value approximates fair value as the nature of these liabilities has historically been short-term. The fair value of these liabilities is classified as Level 2. Other liabilities also include accrued interest on CLO debt. Fair Value Option The Company has elected the fair value option for the financial assets and liabilities of the consolidated CLOs. Management believes that the use of the fair value option better matches the changes in fair value of assets and liabilities related to the CLOs. The following table presents the fair value and unpaid principal balance of loans and debt for which the fair value option has been elected: September 30, 2022 December 31, 2021 (in millions) Syndicated loans Unpaid principal balance $ 2,513 $ 2,233 Excess unpaid principal over fair value (166) (52) Fair value $ 2,347 $ 2,181 Fair value of loans more than 90 days past due $ — $ — Fair value of loans in nonaccrual status 17 13 Difference between fair value and unpaid principal of loans more than 90 days past due, loans in nonaccrual status or both 22 10 Debt Unpaid principal balance $ 2,638 $ 2,296 Excess unpaid principal over fair value (237) (132) Carrying value (1) $ 2,401 $ 2,164 (1) The carrying value of the CLOs’ debt is set equal to the fair value of the CLOs’ assets. The estimated fair value of the CLOs’ debt was $2.4 billion and $2.2 billion as of September 30, 2022 and December 31, 2021, respectively. During the third quarter of 2022, the Company launched one new CLO and issued debt of $352 million. Interest income from syndicated loans, bonds and structured investments is recorded based on contractual rates in Net investment income. Gains and losses related to changes in the fair value of investments are recorded in Net investment income and gains and losses on sales of investments are recorded in Net realized investment gains (losses). Interest expense on debt is recorded in Interest and debt expense with gains and losses related to changes in the fair value of debt recorded in Net investment income. Total net gains (losses) recognized in Net investment income related to the changes in fair value of investments the Company owns in the consolidated CLOs where it has elected the fair value option and collateralized financing entity accounting were immaterial for both the three and nine months ended September 30, 2022 and 2021. Debt of the consolidated investment entities and the stated interest rates were as follows: Carrying Value Weighted Average Interest Rate September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) Debt of consolidated CLOs due 2028-2034 $ 2,401 $ 2,164 4.1 % 1.7 %

Investments

Investments	9 Months Ended
	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Available-for-Sale securities distributed by type were as follows: Description of Securities September 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value (in millions) Fixed maturities: Corporate debt securities $ 9,093 $ 125 $ (958) $ (20) $ 8,240 Residential mortgage backed securities 2,944 — (319) — 2,625 Commercial mortgage backed securities 3,056 — (258) — 2,798 State and municipal obligations 768 57 (26) (2) 797 Asset backed securities 908 11 (27) — 892 Foreign government bonds and obligations 39 — (3) — 36 U.S. government and agency obligations 1 — — — 1 Total $ 16,809 $ 193 $ (1,591) $ (22) $ 15,389 Description of Securities December 31, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value (in millions) Fixed maturities: Corporate debt securities $ 8,447 $ 1,238 $ (47) $ — $ 9,638 Residential mortgage backed securities 2,226 36 (12) — 2,250 Commercial mortgage backed securities 2,615 56 (15) — 2,656 State and municipal obligations 832 244 (1) (1) 1,074 Asset backed securities 517 22 (2) — 537 Foreign government bonds and obligations 80 4 (1) — 83 U.S. government and agency obligations 1 — — — 1 Total $ 14,718 $ 1,600 $ (78) $ (1) $ 16,239 As of September 30, 2022 and December 31, 2021, accrued interest of $139 million and $118 million, respectively, is excluded from the amortized cost basis of Available-for-Sale securities in the tables above and is recorded in Accrued investment income. The Company invested in AA and A rated asset backed securities issued by Ameriprise Advisor Financing, LLC (“AAF”) and in AA, A and BBB rated asset backed securities issued by Ameriprise Advisor Financing 2, LLC (“AAF 2”), both affiliates of the Company. The asset backed securities are collateralized by a portfolio of loans issued to advisors affiliated with AFS, an affiliated broker dealer. As of December 31, 2021, the fair value of these asset backed securities was $289 million. During the third quarter of 2022, the Company redeemed the outstanding AA and A rated securities issued by AAF at par and invested $564 million in new AA, A and BBB rated asset backed securities issued by AAF 2. As of September 30, 2022, the fair value of these asset backed securities was $555 million. As of September 30, 2022 and December 31, 2021, investment securities with a fair value of $3.0 billion and $2.4 billion, respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings, of which $373 million and $314 million, respectively, may be sold, pledged or rehypothecated by the counterparty. As of September 30, 2022 and December 31, 2021, fixed maturity securities comprised approximately 84% and 85% of the Company’s total investments, respectively. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of September 30, 2022 and December 31, 2021, $256 million and $359 million, respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs. A summary of fixed maturity securities by rating was as follows: Ratings September 30, 2022 December 31, 2021 Amortized Cost Fair Value Percent of Total Fair Value Amortized Cost Fair Value Percent of Total Fair Value (in millions, except percentages) AAA $ 6,199 $ 5,612 37 % $ 5,031 $ 5,107 31 % AA 1,071 1,111 7 757 932 6 A 1,443 1,438 9 1,662 2,013 12 BBB 7,431 6,635 43 6,293 7,063 44 Below investment grade (1) 665 593 4 975 1,124 7 Total fixed maturities $ 16,809 $ 15,389 100 % $ 14,718 $ 16,239 100 % (1) The amortized cost and fair value of below investment grade securities includes interest in non-consolidated CLOs managed by the Company of $1 million and $2 million, respectively, as of both September 30, 2022 and December 31, 2021. These securities are not rated but are included in below investment grade due to their risk characteristics. As of September 30, 2022 and December 31, 2021, approximately 36% and 40% of securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities, respectively. As of September 30, 2022, the Company had holdings in AAF 2 totaling $555 million that was 95% of the Company’s total shareholder’s equity. Also, the Company had an additional 59 issuers with holdings totaling $6.3 billion that individually were between 10% and 33% of the Company’s total shareholder’s equity as of September 30, 2022. As of December 31, 2021, the Company had holdings in AAF totaling $289 million that was 16% of the Company’s total shareholder’s equity. Also, the Company had an additional four issuers with holdings totaling $903 million that individually were between 10% and 14% of the Company’s total shareholder’s equity as of December 31, 2021. There were no other holdings of any other issuer greater than 10% of the Company’s total shareholder’s equity as of September 30, 2022 and December 31, 2021. The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded: Description of Securities September 30, 2022 Less than 12 Months 12 Months or More Total Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 429 $ 5,438 $ (670) 70 $ 1,039 $ (288) 499 $ 6,477 $ (958) Residential mortgage backed securities 212 2,098 (204) 25 493 (115) 237 2,591 (319) Commercial mortgage backed securities 190 1,920 (187) 38 452 (71) 228 2,372 (258) State and municipal obligations 52 149 (17) 16 36 (9) 68 185 (26) Asset backed securities 36 779 (23) 2 31 (4) 38 810 (27) Foreign government bonds and obligations 11 32 (2) 1 1 (1) 12 33 (3) Total 930 $ 10,416 $ (1,103) 152 $ 2,052 $ (488) 1,082 $ 12,468 $ (1,591) Description of Securities December 31, 2021 Less than 12 Months 12 Months or More Total Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 102 $ 2,007 $ (42) 14 $ 81 $ (5) 116 $ 2,088 $ (47) Residential mortgage backed securities 55 1,162 (12) 2 1 — 57 1,163 (12) Commercial mortgage backed securities 60 809 (15) 3 13 — 63 822 (15) State and municipal obligations 25 63 (1) — — — 25 63 (1) Asset backed securities 5 91 (2) — — — 5 91 (2) Foreign government bonds and obligations 5 6 — 6 4 (1) 11 10 (1) Total 252 $ 4,138 $ (72) 25 $ 99 $ (6) 277 $ 4,237 $ (78) As part of the Company’s ongoing monitoring process, management determined that the change in gross unrealized losses on its Available-for-Sale securities for which an allowance for credit losses has not been recognized during the nine months ended September 30, 2022 is primarily attributable to the impact of higher interest rates and wider credit spreads driven by continued market volatility, with no specific credit concerns. The Company did not recognize these unrealized losses in earnings because it was determined that such losses were due to non-credit factors. The Company does not intend to sell these securities and does not believe that it is more likely than not that the Company will be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. As of September 30, 2022 and December 31, 2021, approximately 93% and 92%, respectively, of the total of Available-for-Sale securities with gross unrealized losses were considered investment grade. The following table presents a rollforward of the allowance for credit losses on Available-for-Sale securities: Corporate Debt Securities State and Municipal Obligations Total (in millions) Balance at July 1, 2022 $ — $ 1 $ 1 Additions for which credit losses were not previously recorded 20 — 20 Additional increases (decreases) on securities that had an allowance recorded in a previous period — 1 1 Balance at September 30, 2022 $ 20 $ 2 $ 22 Balance at July 1, 2021 $ — $ — $ — Additions for which credit losses were not previously recorded — 1 1 Balance at September 30, 2021 $ — $ 1 $ 1 Balance at January 1, 2022 $ — $ 1 $ 1 Additions for which credit losses were not previously recorded 20 — 20 Additional increases (decreases) on securities that had an allowance recorded in a previous period — 1 1 Balance at September 30, 2022 $ 20 $ 2 $ 22 Balance at January 1, 2021 $ 10 $ — $ 10 Additions for which credit losses were not previously recorded — 1 1 Charge-offs (10) — (10) Balance at September 30, 2021 $ — $ 1 $ 1 Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in Net realized investment gains (losses) were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Gross realized investment gains $ 2 $ 505 $ 24 $ 568 Gross realized investment losses (6) (6) (20) (6) Credit losses (21) (1) (21) (1) Other impairments (61) — (67) (13) Total $ (86) $ 498 $ (84) $ 548 Credit losses for the three and nine months ended September 30, 2022 primarily related to recording an allowance for credit losses on corporate debt securities in the communications industry. Credit losses for the three and nine months ended September 30, 2021 primarily related to recording an allowance for credit losses on a state and municipal security. Other impairments for the three and nine months ended September 30, 2022 and the nine months ended September 30, 2021 related to Available-for-Sale securities which the Company intended to sell. See Note 14 for a rollforward of net unrealized investment gains (losses) included in AOCI. Available-for-Sale securities by contractual maturity as of September 30, 2022 were as follows: Amortized Cost Fair Value (in millions) Due within one year $ 330 $ 328 Due after one year through five years 1,675 1,607 Due after five years through 10 years 3,661 3,085 Due after 10 years 4,235 4,054 9,901 9,074 Residential mortgage backed securities 2,944 2,625 Commercial mortgage backed securities 3,056 2,798 Asset backed securities 908 892 Total $ 16,809 $ 15,389 Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution. The following is a summary of Net investment income: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Fixed maturities $ 156 $ 137 $ 435 $ 511 Mortgage loans 18 21 55 82 Other investments 55 40 92 86 229 198 582 679 Less: investment expenses 5 5 14 15 Total $ 224 $ 193 $ 568 $ 664

Financing Receivables

Financing Receivables	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Financing Receivables	Financing Receivables Financing receivables are comprised of commercial loans, policy loans and deposit receivables. Allowance for Credit Losses The following tables present a rollforward of the allowance for credit losses: Commercial Loans (in millions) Balance at January 1, 2022 $ 12 Provisions (1) Balance at September 30, 2022 $ 11 Commercial Loans (in millions) Balance at January 1, 2021 $ 35 Provisions (21) Balance at September 30, 2021 $ 14 As of September 30, 2022 and December 31, 2021, accrued interest on commercial loans was $12 million and $11 million, respectively, and is recorded in Accrued investment income and excluded from the amortized cost basis of commercial loans. Purchases and Sales There were no commercial mortgage loans sold for the three and nine months ended September 30, 2022. During the three and nine months ended September 30, 2021, the Company sold $746 million of commercial mortgage loans. During the three months ended September 30, 2022 and 2021, the Company purchased nil syndicated loans, and sold nil and $350 million, respectively, of syndicated loans. During the nine months ended September 30, 2022 and 2021, the Company purchased $42 million and $26 million, respectively, of syndicated loans, and sold nil and $354 million, respectively, of syndicated loans. The Company has not acquired any loans with deteriorated credit quality as of the acquisition date. Credit Quality Information Nonperforming loans were $3 million and nil as of September 30, 2022 and December 31, 2021, respectively. All other loans were considered to be performing. Commercial Loans Commercial Mortgage Loans The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Loan-to-value ratio is the primary credit quality indicator included in this review. Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates when credit risk changes. Commercial mortgage loans which management has assigned its highest risk rating were less than 1% of total commercial mortgage loans as of both September 30, 2022 and December 31, 2021. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. Total commercial mortgage loans past due were $3 million and nil as of September 30, 2022 and December 31, 2021, respectively. The tables below present the amortized cost basis of commercial mortgage loans by year of origination and loan-to-value ratio: September 30, 2022 Loan-to-Value Ratio 2022 2021 2020 2019 2018 Prior Total (in millions) > 100% $ — $ — $ 2 $ 2 $ — $ 39 $ 43 80% - 100% 1 9 2 20 8 47 87 60% - 80% 35 87 17 52 10 95 296 40% - 60% 40 84 65 80 55 432 756 < 40% 15 8 27 43 78 462 633 Total $ 91 $ 188 $ 113 $ 197 $ 151 $ 1,075 $ 1,815 December 31, 2021 Loan-to-Value Ratio 2021 2020 2019 2018 2017 Prior Total (in millions) > 100% $ — $ — $ 20 $ 10 $ — $ 29 $ 59 80% - 100% 9 2 9 2 — 29 51 60% - 80% 141 76 59 15 58 133 482 40% - 60% 37 30 75 74 49 393 658 < 40% 6 8 46 — 47 443 550 Total $ 193 $ 116 $ 209 $ 101 $ 154 $ 1,027 $ 1,800 Loan-to-value ratio is based on income and expense data provided by borrowers at least annually and long-term capitalization rate assumptions based on property type. In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: Loans Percentage September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) East North Central $ 199 $ 183 11 % 10 % East South Central 52 54 3 3 Middle Atlantic 95 107 5 6 Mountain 122 111 7 6 New England 17 21 1 1 Pacific 603 589 33 33 South Atlantic 484 477 27 26 West North Central 127 136 7 8 West South Central 116 122 6 7 1,815 1,800 100 % 100 % Less: allowance for credit losses 11 12 Total $ 1,804 $ 1,788 Concentrations of credit risk of commercial mortgage loans by property type were as follows: Loans Percentage September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) Apartments $ 479 $ 464 26 % 26 % Hotel 14 15 1 1 Industrial 292 293 16 16 Mixed use 55 57 3 3 Office 250 254 14 14 Retail 593 589 33 33 Other 132 128 7 7 1,815 1,800 100 % 100 % Less: allowance for credit losses 11 12 Total $ 1,804 $ 1,788 Syndicated Loans The recorded investment in syndicated loans as of September 30, 2022 and December 31, 2021 was $76 million and $43 million, respectively. The Company’s syndicated loan portfolio is diversified across industries and issuers. Total syndicated loans past due were nil as of both September 30, 2022 and December 31, 2021. The Company assigns an internal risk rating to each syndicated loan in its portfolio ranging from 1 through 5, with 5 reflecting the lowest quality. The tables below present the amortized cost basis of syndicated loans by origination year and internal risk rating: September 30, 2022 Internal Risk Rating 2022 2021 2020 2019 2018 Prior Total (in millions) Risk 5 $ — $ — $ — $ — $ — $ — $ — Risk 4 — — — — — — — Risk 3 — 5 — 3 — 2 10 Risk 2 5 13 2 5 — 15 40 Risk 1 1 5 1 3 5 11 26 Total $ 6 $ 23 $ 3 $ 11 $ 5 $ 28 $ 76 December 31, 2021 Internal Risk Rating 2021 2020 2019 2018 2017 Prior Total (in millions) Risk 5 $ — $ — $ — $ — $ — $ — $ — Risk 4 — — — — — — — Risk 3 — — — — — 1 1 Risk 2 11 — 4 1 8 4 28 Risk 1 4 — — 3 3 4 14 Total $ 15 $ — $ 4 $ 4 $ 11 $ 9 $ 43 Policy Loans Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses. Deposit Receivables Deposit receivables were $7.5 billion and $7.9 billion as of September 30, 2022 and December 31, 2021, respectively. Deposit receivables are fully collateralized by the fair value of the assets held in trusts. Based on management’s evaluation of the nature of the underlying assets and the potential for changes in the collateral value, there was no allowance for credit losses for deposit receivables as of September 30, 2022 and December 31, 2021. Troubled Debt Restructurings

Deferred Acquisition Costs and

Deferred Acquisition Costs and Deferred Sales Inducement Costs	9 Months Ended
	Sep. 30, 2022
Deferred Charges, Insurers [Abstract]
Deferred Acquisition Costs and Deferred Sales Inducement Costs	Deferred Acquisition Costs and Deferred Sales Inducement Costs During the third quarter of the year, management updated market-related inputs and implemented model changes related to the living benefit valuation. In addition, management conducted its annual review of life insurance and annuity valuation assumptions relative to current experience and management expectations including modeling changes. These aforementioned changes are collectively referred to as unlocking. The impact of unlocking to deferred acquisition costs (“DAC”) in the third quarter of 2022 primarily reflected a $49 million increase from lower surrenders on variable annuities with living benefits and universal life (“UL”) and variable universal life (“VUL”) insurance products partially offset by a $27 million decrease from updating mortality assumptions for variable annuities and a $13 million decrease from updating the fair value discount rate for variable annuities. The impact of unlocking to DAC in the third quarter of 2021 primarily reflected a favorable impact from lower surrenders on variable annuities with living benefits and UL and VUL insurance products. The balances of and changes in DAC were as follows: 2022 2021 (in millions) Balance at January 1 $ 2,757 $ 2,508 Capitalization of acquisition costs 146 196 Amortization (351) (129) Amortization, impact of valuation assumptions review 8 60 Impact of change in net unrealized (gains) losses on securities 420 75 Balance at September 30 $ 2,980 $ 2,710 The balances of and changes in deferred sales inducement costs (“DSIC”), which is included in Other assets, were as follows: 2022 2021 (in millions) Balance at January 1 $ 187 $ 187 Capitalization of sales inducement costs 1 1 Amortization (34) (15) Amortization, impact of valuation assumptions review 2 2 Impact of change in net unrealized (gains) losses on securities 15 11 Balance at September 30 $ 171 $ 186

Policyholder Account Balances,

Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities	9 Months Ended
	Sep. 30, 2022
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities [Abstract]
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities	Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities Policyholder account balances, future policy benefits and claims consisted of the following: September 30, 2022 December 31, 2021 (in millions) Policyholder account balances Fixed annuities (1) $ 7,776 $ 8,117 Variable annuity fixed sub-accounts 4,887 4,990 UL/VUL insurance 3,069 3,103 Indexed universal life (“IUL”) insurance 2,645 2,534 Structured variable annuities 5,314 4,440 Other life insurance 533 563 Total policyholder account balances 24,224 23,747 Future policy benefits Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) 2,101 2,336 Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (2) 64 (23) Other annuity liabilities 316 67 Fixed annuity life contingent liabilities 1,215 1,278 Life and disability income insurance 1,106 1,139 Long term care insurance 5,187 5,664 UL/VUL and other life insurance additional liabilities 1,048 1,291 Total future policy benefits 11,037 11,752 Policy claims and other policyholders’ funds 214 245 Total policyholder account balances, future policy benefits and claims $ 35,475 $ 35,744 (1) Includes fixed deferred annuities, non-life contingent fixed payout annuities and fixed deferred indexed annuity host contracts. (2) Includes the fair value of GMAB embedded derivatives that was a net asset as of December 31, 2021 and the amount is presented as a contra liability. Separate account liabilities consisted of the following: September 30, 2022 December 31, 2021 (in millions) Variable annuity $ 61,063 $ 82,862 VUL insurance 7,090 9,343 Other insurance 24 33 Total $ 68,177 $ 92,238

Variable Annuity and Insurance

Variable Annuity and Insurance Guarantees	9 Months Ended
	Sep. 30, 2022
Insurance [Abstract]
Variable Annuity and Insurance Guarantees	Variable Annuity and Insurance Guarantees Most of the variable annuity contracts issued by the Company contain one or more guaranteed minimum death benefit (“GMDB”) provisions or death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. The Company discontinued new sales of substantially all GMWB and GMAB at the end of 2021. The Company also previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions. Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: Variable Annuity Guarantees by Benefit Type (1) September 30, 2022 December 31, 2021 Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age (in millions, except age) GMDB: Return of premium $ 51,949 $ 50,290 $ 1,440 69 $ 70,020 $ 68,145 $ 6 69 Five/six-year reset 6,652 3,986 277 69 8,309 5,612 6 68 One-year ratchet 4,612 4,306 1,019 72 6,177 5,858 13 71 Five-year ratchet 1,058 1,009 106 68 1,438 1,386 1 68 Other 964 950 284 75 1,302 1,286 38 74 Total — GMDB $ 65,235 $ 60,541 $ 3,126 69 $ 87,246 $ 82,287 $ 64 69 GGU death benefit $ 966 $ 909 $ 139 72 $ 1,260 $ 1,198 $ 184 72 GMIB $ 130 $ 117 $ 14 72 $ 184 $ 170 $ 4 71 GMWB: GMWB $ 1,351 $ 1,346 $ 54 75 $ 1,900 $ 1,895 $ 1 75 GMWB for life 37,871 37,865 3,090 70 52,387 52,334 187 69 Total — GMWB $ 39,222 $ 39,211 $ 3,144 70 $ 54,287 $ 54,229 $ 188 69 GMAB $ 1,391 $ 1,391 $ 187 62 $ 2,005 $ 2,005 $ — 62 (1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. The net amount at risk for GMDB, GGU and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero. The following table provides information related to insurance guarantees for which the Company has established additional liabilities: September 30, 2022 December 31, 2021 Net Amount at Risk Weighted Average Attained Age Net Amount at Risk Weighted Average Attained Age (in millions, except age) UL secondary guarantees $ 6,496 69 $ 6,564 68 Structured variable annuity GMDB $ 723 64 $ 3 63 The net amount at risk for UL secondary guarantees and structured variable annuity GMDB is defined as the current guaranteed death benefit amount in excess of the current policyholder account balance. Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: GMDB & GGU GMIB GMWB (1) GMAB (1) UL (in millions) Balance at January 1, 2022 $ 36 $ 5 $ 2,336 $ (23) $ 1,020 Incurred claims 40 2 (235) 87 87 Paid claims (15) — — — (31) Balance at September 30, 2022 $ 61 $ 7 $ 2,101 $ 64 $ 1,076 Balance at January 1, 2021 $ 24 $ 6 $ 3,049 $ 1 $ 916 Incurred claims 12 1 (793) (15) 106 Paid claims (3) (1) — — (27) Balance at September 30, 2021 $ 33 $ 6 $ 2,256 $ (14) $ 995 (1) The incurred claims for GMWB and GMAB include the change in the fair value of the liabilities (contra liabilities) less paid claims. The liabilities for guaranteed benefits are supported by general account assets. The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: September 30, 2022 December 31, 2021 (in millions) Mutual funds: Equity $ 38,594 $ 49,183 Bond 21,012 24,998 Other 6,224 8,316 Total mutual funds $ 65,830 $ 82,497

Debt

Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt Short-Term Borrowings RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in Investments and was $1.3 billion and $1.0 billion as of September 30, 2022 and December 31, 2021, respectively. The amount of the Company’s liability including accrued interest was $201 million and $200 million as of September 30, 2022 and December 31, 2021, respectively. The remaining maturity of outstanding FHLB advances was less than three months as of both September 30, 2022 and December 31, 2021. The weighted average annualized interest rate on the FHLB advances held as of September 30, 2022 and December 31, 2021 was 3.2% and 0.3%, respectively. Long-Term Debt The Company has a $500 million unsecured 3.5% surplus note due December 31, 2050 to Ameriprise Financial. The outstanding balance was $500 million as of both September 30, 2022 and December 31, 2021 and is recorded in Long-term debt.

Fair Values of Assets and Liabi

Fair Values of Assets and Liabilities	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities	Fair Values of Assets and Liabilities GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale. Valuation Hierarchy The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows: Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The following tables present the balances of assets and liabilities measured at fair value on a recurring basis (See Note 4 for the balances of assets and liabilities for consolidated investment entities): September 30, 2022 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Corporate debt securities $ — $ 7,846 $ 394 $ 8,240 Residential mortgage backed securities — 2,625 — 2,625 Commercial mortgage backed securities — 2,798 — 2,798 State and municipal obligations — 797 — 797 Asset backed securities — 336 556 892 Foreign government bonds and obligations — 36 — 36 U.S. government and agency obligations 1 — — 1 Total Available-for-Sale securities 1 14,438 950 15,389 Cash equivalents 1,155 1,318 — 2,473 Receivables: Fixed deferred indexed annuity ceded embedded derivatives — — 47 47 Other assets: Interest rate derivative contracts 15 362 — 377 Equity derivative contracts 137 2,519 — 2,656 Foreign exchange derivative contracts 1 88 — 89 Credit derivative contracts — 76 — 76 Total other assets 153 3,045 — 3,198 Separate account assets at net asset value (“NAV”) 68,177 (1) Total assets at fair value $ 1,309 $ 18,801 $ 997 $ 89,284 Liabilities Policyholder account balances, future policy benefits and claims: Fixed deferred indexed annuity embedded derivatives $ — $ 3 $ 43 $ 46 IUL embedded derivatives — — 689 689 GMWB and GMAB embedded derivatives — — 932 932 (2) Structured variable annuity embedded derivatives — — (513) (513) (3) Total policyholder account balances, future policy benefits and claims — 3 1,151 1,154 (4) Other liabilities: Interest rate derivative contracts 3 582 — 585 Equity derivative contracts 153 2,328 — 2,481 Foreign exchange derivative contracts 2 12 — 14 Total other liabilities 158 2,922 — 3,080 Total liabilities at fair value $ 158 $ 2,925 $ 1,151 $ 4,234 December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Corporate debt securities $ — $ 9,142 $ 496 $ 9,638 Residential mortgage backed securities — 2,250 — 2,250 Commercial mortgage backed securities — 2,656 — 2,656 State and municipal obligations — 1,074 — 1,074 Asset backed securities — 246 291 537 Foreign government bonds and obligations — 83 — 83 U.S. government and agency obligations 1 — — 1 Total Available-for-Sale securities 1 15,451 787 16,239 Cash equivalents 1,985 1,191 — 3,176 Receivables: Fixed deferred indexed annuity ceded embedded derivatives — — 59 59 Other assets: Interest rate derivative contracts 1 1,251 — 1,252 Equity derivative contracts 158 4,080 — 4,238 Foreign exchange derivative contracts 1 17 — 18 Credit derivative contracts — 9 — 9 Total other assets 160 5,357 — 5,517 Separate account assets at NAV 92,238 (1) Total assets at fair value $ 2,146 $ 21,999 $ 846 $ 117,229 Liabilities Policyholder account balances, future policy benefits and claims: Fixed deferred indexed annuity embedded derivatives $ — $ 5 $ 56 $ 61 IUL embedded derivatives — — 905 905 GMWB and GMAB embedded derivatives — — 1,486 1,486 (5) Structured variable annuity embedded derivatives — — 406 406 Total policyholder account balances, future policy benefits and claims — 5 2,853 2,858 (6) Other liabilities: Interest rate derivative contracts 1 467 — 468 Equity derivative contracts 101 3,610 — 3,711 Foreign exchange derivative contracts 1 — — 1 Total other liabilities 103 4,077 — 4,180 Total liabilities at fair value $ 103 $ 4,082 $ 2,853 $ 7,038 (1) Amounts are comprised of certain financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $1.2 billion of individual contracts in a liability position and $224 million of individual contracts in an asset position (recorded as a contra liability) as of September 30, 2022. ( 3 ) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability. (4) The Company’s adjustment for nonperformance risk resulted in a $778 million cumulative decrease to the embedded derivatives as of September 30, 2022. (5) The fair value of the GMWB and GMAB embedded derivatives included $1.6 billion of individual contracts in a liability position and $133 million of individual contracts in an asset position (recorded as a contra liability) as of December 31, 2021. (6) The Company’s adjustment for nonperformance risk resulted in a $598 million cumulative decrease to the embedded derivatives as of December 31, 2021. The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Differed Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2022 $ 458 $ 236 $ 694 $ 49 Total gains (losses) included in: Net income — — — (2) Other comprehensive income (loss) (13) (3) (16) — Purchases 6 564 570 — Settlements (57) (241) (298) — Balance at September 30, 2022 $ 394 $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (13) $ (10) $ (23) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2022 $ 45 $ 719 $ 1,006 $ (362) (4) $ 1,408 Total (gains) losses included in: Net income (1) (2) (22) (2) (152) (3) (173) (3) (348) Issues — 18 89 19 126 Settlements (1) (26) (11) 3 (35) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (22) (2) $ (146) (3) $ (173) (3) $ (341) Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2021 $ 385 $ 336 $ 721 $ — Total gains (losses) included in: Net income (1) — (1) (1) — Other comprehensive income (loss) (3) — (3) — Purchases 9 — 9 — Issues — — — 57 Settlements (44) (20) (64) (1) Transfers into Level 3 168 2 170 — Balance at September 30, 2021 $ 514 $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ (4) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2021 $ 54 $ 928 $ 1,373 $ 214 $ 2,569 Total (gains) losses included in: Net income 1 (2) 14 (2) (69) (3) 17 (3) (37) Issues — — 95 (7) 88 Settlements (1) (25) 37 (7) 4 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 14 (2) $ (60) (3) $ — $ (46) Available-for-Sale Securities Receivables Corporate Debt Securities Commercial Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2022 $ 496 $ — $ 291 $ 787 $ 59 Total gains (losses) included in: Net income (1) — — (1) (1) (10) Other comprehensive income (loss) (46) — (14) (60) — Purchases 29 30 564 623 — Settlements (84) — (285) (369) (2) Transfers out of Level 3 — (30) — (30) — Balance at September 30, 2022 $ 394 $ — $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in net income relating to assets held at September 30, 2022 $ (1) $ — $ — $ (1) (1) $ — Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (45) $ — $ (10) $ (55) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2022 $ 56 $ 905 $ 1,486 $ 406 $ 2,853 Total (gains) losses included in: Net income (10) (2) (162) (2) (727) (3) (939) (3) (1,838) Issues — 26 260 37 323 Settlements (3) (80) (87) (17) (187) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (162) (2) $ (709) (3) $ (939) (3) $ (1,810) Available-for-Sale Securities Receivables Corporate Debt Securities Residential Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2021 $ 766 $ 9 $ 395 $ 1,170 $ — Total gains (losses) included in: Net income (1) — — (1) (1) — Other comprehensive income (loss) (6) — 3 (3) — Purchases 76 — — 76 — Issues — — — — 57 Settlements (73) — (58) (131) (1) Transfers into Level 3 168 — 2 170 — Transfers out of Level 3 (416) (9) (24) (449) — Balance at September 30, 2021 $ 514 $ — $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ 3 $ (1) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2021 $ 49 $ 935 $ 2,316 $ 70 $ 3,370 Total (gains) losses included in: Net income 7 (2) 51 (2) (1,273) (3) 192 (3) (1,023) Issues — 4 274 (22) 256 Settlements (2) (73) 119 (23) 21 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 51 (2) $ (1,236) (3) $ — $ (1,185) (1) Included in Net investment income. (2) Included in Interest credited to fixed accounts. (3) Included in Benefits, claims, losses and settlement expenses. (4) The fair value of the structured variable annuity embedded derivatives was a net asset as of both June 30, 2022 and September 30, 2022 and the amounts are presented as contra liabilities. The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $(37) million and $1 million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual, for the three months ended September 30, 2022 and 2021, respectively. The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $182 million and $(138) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual, for the nine months ended September 30, 2022 and 2021, respectively. Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs or fair values that were included in an observable transaction with a market participant. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote. The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: September 30, 2022 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 394 Discounted cash flow Yield/spread to U.S. Treasuries (1) 1.0% – 3.6% 1.5% Asset backed securities $ 556 Discounted cash flow Annual default rate 2.6% 2.6% Loss severity 25.0% 25.0% Yield/spread to U.S. Treasuries (2) 270 bps – 450 bps 277 bps Fixed deferred indexed annuity ceded embedded derivatives $ 47 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% IUL embedded derivatives $ 689 Discounted cash flow Nonperformance risk (4) 125 bps 125 bps Fixed deferred indexed annuity embedded derivatives $ 43 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% Nonperformance risk (4) 125 bps 125 bps GMWB and GMAB embedded derivatives $ 932 Discounted cash flow Utilization of guaranteed withdrawals (6) (7) 0.0% – 48.0% 10.9% Surrender rate (5) 0.1% – 55.7% 3.4% Market volatility (8) (9) 5.0% – 17.5% 12.1% Nonperformance risk (4) 125 bps 125 bps Structured variable annuity embedded derivatives $ (513) (10) Discounted cash flow Surrender rate (5) 0.8% – 40.0% 0.9% Nonperformance risk (4) 125 bps 125 bps December 31, 2021 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 496 Discounted cash flow Yield/spread to U.S. Treasuries (1) 0.8% – 2.4% 1.1% Asset backed securities $ 291 Discounted cash flow Annual default rate 5.8% 5.8% Loss severity 25.0% 25.0% Yield/spread to swap rates (3) 175 bps – 275 bps 182 bps Fixed deferred indexed annuity ceded embedded derivatives $ 59 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% IUL embedded derivatives $ 905 Discounted cash flow Nonperformance risk (4) 65 bps 65 bps Fixed deferred indexed annuity embedded derivatives $ 56 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% Nonperformance risk (4) 65 bps 65 bps GMWB and GMAB embedded derivatives $ 1,486 Discounted cash flow Utilization of guaranteed withdrawals (6) (7) 0.0% – 48.0% 10.6% Surrender rate (5) 0.1% – 55.7% 3.6% Market volatility (8) (9) 4.3% – 16.8% 10.8% Nonperformance risk (4) 65 bps 65 bps Structured variable annuity embedded derivatives $ 406 Discounted cash flow Surrender rate (5) 0.8% – 40.0% 0.9% Nonperformance risk (4) 65 bps 65 bps (1) The weighted average for the spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities. (2) The weighted average for the spread to U.S. Treasuries for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to U.S. Treasuries divided by the aggregate balances of the tranches. (3) The weighted average for the spread to swap rates for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to swap divided by the aggregate balances of the tranches. (4) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. During the third quarter of 2022, the Company changed to using a U.S. Treasury curve as its observable discount rate curve reflecting the evolution of LIBOR discontinuation as an observable reference rate used by market participants. (5) The weighted average surrender rate is weighted based on the benefit base of each contract and represents the average assumption in the current year including the effect of a dynamic surrender formula. (6) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (7) The weighted average utilization rate represents the average assumption for the current year, weighting each policy evenly. The calculation excludes policies that have already started taking withdrawals. (8) Market volatility represents the implied volatility of fund of funds and managed volatility funds. (9) The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit. (10) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability. Level 3 measurements not included in the tables above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company. Uncertainty of Fair Value Measurements Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities and asset backed securities in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in the annual default rate used in the fair value measurement of Level 3 asset backed securities in isolation, generally, would have resulted in a significantly lower (higher) fair value measurement and significant increases (decreases) in loss severity in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in the yield/spread to swap rates in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in the surrender rate used in the fair value measurement of the fixed deferred indexed annuity ceded embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurements of the fixed deferred indexed annuity embedded derivatives and structured variable annuity embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value. Significant increases (decreases) in utilization and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly higher (lower) liability value. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution channel and whether the value of the guaranteed benefit exceeds the contract accumulation value. Determination of Fair Value The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy. Assets Available-for-Sale Securities When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques. Level 1 securities primarily include U.S. Treasuries. Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. The fair value of securities included in an observable transaction with a market participant are also considered Level 2 when the market is not active. Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities, commercial mortgage backed securities and asset backed securities with fair value typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. The fair value of affiliated asset backed securities is determined using a discounted cash flow model. Inputs used to determine the expected cash flows include assumptions about discount rates and default, prepayment and recovery rates of the underlying assets. Given the significance of the unobservable inputs to this fair value measurement, the fair value of the investment in the affiliated asset backed securities is classified as Level 3. In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise. Cash Equivalents Cash equivalents include time deposits and other highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. Actively traded money market funds are measured at their NAV and classified as Level 1. U.S. Treasuries are also classified as Level 1. The Company’s remaining cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization. Receivables The Company reinsured its fixed deferred indexed annuity products which have an indexed account that is accounted for as an embedded derivative. The Company uses discounted cash flow models to determine the fair value of these ceded embedded derivatives. The fair value of fixed deferred indexed annuity ceded embedded derivatives includes significant observable interest rates, volatilities and equity index levels and significant unobservable surrender rates. Given the significance of the unobservable surrender rates, these embedded derivatives are classified as Level 3. Other Assets Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of both September 30, 2022 and December 31, 2021. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. Separate Account Assets The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy. Liabilities Policyholder Account Balances, Future Policy Benefits and Claims There is no active market for the transfer of the Company’s embedded derivatives attributable to the provisions of certain variable annuity riders, fixed deferred indexed annuity, structured variable annuity and IUL products. The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value as the present value of future expected benefit payments less the present value of future expected rider fees attributable to the embedded derivative feature. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to implied volatility as well as contractholder behavior assumptions that include margins for risk, all of which the Company believes a market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in Policyholder account balances, future policy benefits and claims. The Company uses a discounted cash flow model to determine the fair value of the embedded derivatives associated with the provisions of its equity index annuity product. The projected cash flows generated by this model are based on significant observable inputs related to interest rates, volatilities and equity index levels and, therefore, are classified as Level 2. The Company uses discounted cash flow models to determine the fair value of the embedded derivatives associated with the provisions of its fixed deferred indexed annuity, structured variable annuity and IUL products. The structured variable annuity product is a limited flexible purchase payment annuity that offers 45 different indexed account options providing equity market exposure and a fixed account. Each indexed account includes a protection option (a buffer or a floor). If the index has a negative return, contractholder losses will be reduced by a buffer or limited to a floor. The portion allocated to an indexed account is accounted for as an embedded derivative. The fair value of fixed deferred indexed annuity, structured variable annuity and IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and significant unobservable surrender rates and the estimate of the Company’s nonperformance risk. Given the significance of the unobservable surrender rates and the nonperformance risk assumption, the fixed deferred indexed annuity, structured variable annuity and IUL embedded derivatives are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in Policyholder account balances, future policy benefits and claims. Other Liabilities Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both September 30, 2022 and December 31, 2021. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. Fair Value on a Nonrecurring Basis The Company assesses its investment in affordable housing partnerships for impairment. The investments that are determined to be impaired are written down to their fair value. The Company uses a discounted cash flow model to measure the fair value of these investments. Inputs to the discounted cash flow model are estimates of future net operating losses and tax credits available to the Company and discount rates based on market condition and the financial strength of the syndicator (general partner). The balance of affordable housing partnerships measured at fair value on a nonrecurring basis was $63 million and $93 million as of September 30, 2022 and December 31, 2021, respectively, and is classified as Level 3 in the fair value hierarchy. Assets and Liabilities Not Reported at Fair Value The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value: September 30, 2022 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 1,804 $ — $ — $ 1,627 $ 1,627 Policy loans 838 — 838 — 838 Other investments 94 — 72 21 93 Receivables 7,528 — — 6,264 6,264 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 14,041 $ — $ — $ 12,048 $ 12,048 Short-term borrowings 201 — 201 — 201 Long-term debt 500 — 313 — 313 Other liabilities 8 — — 7 7 Separate account liabilities — investment contracts 288 — 288 — 288 December 31, 2021 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 1,788 $ — $ — $ 1,872 $ 1,872 Policy loans 834 — 834 — 834 Other investments 61 — 40 21 61 Receivables 7,876 — — 8,630 8,630 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 12,342 $ — $ — $ 13,264 $ 13,264 Short-term borrowings 200 — 200 — 200 Long-term debt 500 — 498 — 498 Other liabilities 9 — — 9 9 Separate account liabilities — investment contracts 403 — 403 — 403 Other investments include syndicated loans and the Company’s membership in the FHLB. Receivables include the deposit receivables. See Note 6 for additional information on mortgage loans, policy loans, syndicated loans and deposit receivables. Policyholder account balances, future policy benefits and claims include fixed annuities in deferral status, non-life contingent fixed annuities in payout status, indexed and structured variable annuity host contracts, and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 8 for additional information on these liabilities. Short-term borrowings include FHLB borrowings. Long-term debt includes the surplus note with Ameriprise Financial. See Note 10 for further information on short-term borrowings and long-term debt. Other liabilities include future funding commitments to affordable housing partnerships and other real estate partnerships. Separate account liabilities are relate

Offsetting Assets and Liabiliti

Offsetting Assets and Liabilities	9 Months Ended
	Sep. 30, 2022
Offsetting [Abstract]
Offsetting Assets and Liabilities	Offsetting Assets and Liabilities Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: September 30, 2022 Gross Amounts of Recognized Assets Gross Amounts Offset in the Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,975 $ — $ 2,975 $ (2,386) $ (552) $ (7) $ 30 OTC cleared 105 — 105 (105) — — — Exchange-traded 118 — 118 (79) — — 39 Total derivatives $ 3,198 $ — $ 3,198 $ (2,570) $ (552) $ (7) $ 69 December 31, 2021 Gross Amounts of Recognized Assets Gross Amounts Offset in the Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 5,330 $ — $ 5,330 $ (3,571) $ (1,623) $ (114) $ 22 OTC cleared 88 — 88 (41) — — 47 Exchange-traded 99 — 99 (91) — — 8 Total derivatives $ 5,517 $ — $ 5,517 $ (3,703) $ (1,623) $ (114) $ 77 (1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: September 30, 2022 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,791 $ — $ 2,791 $ (2,386) $ (70) $ (322) $ 13 OTC cleared 201 — 201 (105) — — 96 Exchange-traded 88 — 88 (79) — (9) — Total derivatives $ 3,080 $ — $ 3,080 $ (2,570) $ (70) $ (331) $ 109 December 31, 2021 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 4,048 $ — $ 4,048 $ (3,571) $ (181) $ (293) $ 3 OTC cleared 41 — 41 (41) — — — Exchange-traded 91 — 91 (91) — — — Total derivatives $ 4,180 $ — $ 4,180 $ (3,703) $ (181) $ (293) $ 3 (1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables. When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral. Freestanding derivative instruments are reflected in Other assets and Other liabilities. Cash collateral pledged by the Company is reflected in Other assets and cash collateral accepted by the Company is reflected in Other liabilities. See Note 13 for additional disclosures related to the Company’s derivative instruments.

Derivatives and Hedging Activit

Derivatives and Hedging Activities	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging Activities	Derivatives and Hedging Activities Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations. Certain of the Company’s freestanding derivative instruments are subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 12 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral. Generally, the Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives: September 30, 2022 December 31, 2021 Notional Gross Fair Value Notional Gross Fair Value Assets (1) Liabilities (2)(3) Assets (1) Liabilities (2)(3) (in millions) Derivatives not designated as hedging instruments Interest rate contracts $ 95,693 $ 377 $ 585 $ 79,459 $ 1,252 $ 468 Equity contracts 67,418 2,656 2,481 59,763 4,238 3,711 Credit contracts 1,684 76 — 1,717 9 — Foreign exchange contracts 2,516 89 14 2,239 18 1 Total non-designated hedges 167,311 3,198 3,080 143,178 5,517 4,180 Embedded derivatives GMWB and GMAB (4) N/A — 932 N/A — 1,486 IUL N/A — 689 N/A — 905 Fixed deferred indexed annuities and deposit receivables N/A 47 46 N/A 59 61 Structured variable annuities (5) N/A — (513) N/A — 406 Total embedded derivatives N/A 47 1,154 N/A 59 2,858 Total derivatives $ 167,311 $ 3,245 $ 4,234 $ 143,178 $ 5,576 $ 7,038 N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets and the fair value of ceded embedded derivative assets related to deposit receivables is included in Receivables. (2) The fair value of freestanding derivative liabilities is included in Other liabilities. The fair value of GMWB and GMAB, IUL, fixed deferred indexed annuity and structured variable annuity embedded derivatives is included in Policyholder account balances, future policy benefits and claims. (3) The fair value of the Company’s derivative liabilities after considering the effects of master netting arrangements, cash collateral held by the same counterparty and the fair value of net embedded derivatives was $1.6 billion and $3.2 billion as of September 30, 2022 and December 31, 2021, respectively. See Note 12 for additional information related to master netting arrangements and cash collateral. (4) The fair value of the GMWB and GMAB embedded derivatives as of September 30, 2022 included $1.2 billion of individual contracts in a liability position and $224 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2021 included $1.6 billion of individual contracts in a liability position and $133 million of individual contracts in an asset position. (5) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability. See Note 11 for additional information regarding the Company’s fair value measurement of derivative instruments. As of September 30, 2022 and December 31, 2021, investment securities with a fair value of $7 million and $123 million, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which $7 million and $123 million, respectively, may be sold, pledged or rehypothecated by the Company. As of both September 30, 2022 and December 31, 2021, the Company had sold, pledged, or rehypothecated none of these securities. In addition, as of both September 30, 2022 and December 31, 2021, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets. The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income: Net Investment Income Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended September 30, 2022 Interest rate contracts $ — $ — $ (753) Equity contracts — (23) 341 Credit contracts — — 92 Foreign exchange contracts — — 112 GMWB and GMAB embedded derivatives — — 71 IUL embedded derivatives — 48 — Structured variable annuity embedded derivatives — — 173 Total gain (loss) $ — $ 25 $ 36 Three Months Ended September 30, 2021 Interest rate contracts $ — $ — $ (171) Equity contracts — — 1 Credit contracts — — 2 GMWB and GMAB embedded derivatives — — (64) IUL embedded derivatives — 11 — Fixed deferred indexed annuity embedded derivatives — 1 — Structured variable annuity embedded derivatives — — (17) Total gain (loss) $ — $ 12 $ (249) Net Investment Income Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Nine Months Ended September 30, 2022 Interest rate contracts $ — $ — $ (2,815) Equity contracts — (135) 1,066 Credit contracts — — 288 Foreign exchange contracts — — 219 GMWB and GMAB embedded derivatives — — 551 IUL embedded derivatives — 242 — Fixed deferred indexed annuity and deposit receivables embedded derivatives — 3 — Structured variable annuity embedded derivatives — — 939 Total gain (loss) $ — $ 110 $ 248 Nine Months Ended September 30, 2021 Interest rate contracts $ — $ — $ (1,125) Equity contracts 1 55 (613) Credit contracts — — 41 Foreign exchange contracts — — 6 GMWB and GMAB embedded derivatives — — 879 IUL embedded derivatives — 22 — Fixed deferred indexed annuity embedded derivatives — (7) — Structured variable annuity embedded derivatives — — (192) Total gain (loss) $ 1 $ 70 $ (1,004) The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company. Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The indexed portion of structured variable annuities and the GMAB and non-life contingent GMWB provisions are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. The Company economically hedges the aggregate exposure related to the indexed portion of structured variable annuities and the GMAB and non-life contingent GMWB provisions using options, swaptions, swaps and futures. The deferred premium associated with certain of the above options and swaptions is paid or received semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of September 30, 2022: Premiums Payable Premiums Receivable (in millions) 2022 (1) $ 37 $ 62 2023 50 43 2024 130 23 2025 118 20 2026 249 88 2027 - 2029 77 — Total $ 661 $ 236 (1) 2022 amounts represent the amounts payable and receivable for the period from October 1, 2022 to December 31, 2022. Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received. The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives may contain settlement provisions linked to both equity returns and interest rates. The Company’s macro hedge derivatives that contain settlement provisions linked to both equity returns and interest rates, if any, are shown in other contracts in the tables above. Structured variable annuity and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to structured variable annuity and IUL products will positively or negatively impact earnings over the life of these products. The equity component of structured variable annuity and IUL product obligations are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts. Cash Flow Hedges During both the three and nine months ended September 30, 2022 and 2021, the Company held no derivatives that were designated as cash flow hedges. During both the three and nine months ended September 30, 2022 and 2021, no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy. Credit Risk Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 12 for additional information on the Company’s credit exposure related to derivative assets. Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could

Shareholder's Equity

Shareholder's Equity	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Shareholder's Equity	Shareholder’s Equity The following tables provide the amounts related to each component of OCI: Three Months Ended September 30, 2022 2021 Pretax Income Tax Benefit (Expense) Net of Tax Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized gains (losses) on securities: Net unrealized gains (losses) on securities arising during the period (1) $ (842) $ 178 $ (664) $ (57) $ 14 $ (43) Reclassification of net (gains) losses on securities included in net income (2) 86 (19) 67 (498) 104 (394) Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables 219 (46) 173 147 (31) 116 Net unrealized gains (losses) on securities (537) 113 (424) (408) 87 (321) Total other comprehensive income (loss) $ (537) $ 113 $ (424) $ (408) $ 87 $ (321) Nine Months Ended September 30, 2022 2021 Pretax Income Tax Benefit (Expense) Net of Tax Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized gains (losses) on securities: Net unrealized gains (losses) on securities arising during the period (1) $ (3,004) $ 639 $ (2,365) $ (396) $ 86 $ (310) Reclassification of net (gains) losses on securities included in net income (2) 84 (18) 66 (548) 115 (433) Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables 1,145 (240) 905 284 (60) 224 Net unrealized gains (losses) on securities (1,775) 381 (1,394) (660) 141 (519) Total other comprehensive income (loss) $ (1,775) $ 381 $ (1,394) $ (660) $ 141 $ (519) (1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period. (2) Reclassification amounts are recorded in Net realized investment gains (losses). Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the fair value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit impairments to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates. The following table presents the changes in the balances of each component of AOCI, net of tax: Net Unrealized Gains (Losses) on Securities Other Total (in millions) Balance at July 1, 2022 $ (641) $ (1) $ (642) OCI before reclassifications (491) — (491) Amounts reclassified from AOCI 67 — 67 Total OCI (424) — (424) Balance at September 30, 2022 $ (1,065) $ (1) $ (1,066) Balance at July 1, 2021 $ 723 $ (1) $ 722 OCI before reclassifications 73 — 73 Amounts reclassified from AOCI (394) — (394) Total OCI (321) — (321) Balance at September 30, 2021 $ 402 $ (1) $ 401 Balance at January 1, 2022 $ 329 $ (1) $ 328 OCI before reclassifications (1,460) — (1,460) Amounts reclassified from AOCI 66 — 66 Total OCI (1,394) — (1,394) Balance at September 30, 2022 $ (1,065) (1) $ (1) $ (1,066) Balance at January 1, 2021 $ 921 $ (1) $ 920 OCI before reclassifications (86) — (86) Amounts reclassified from AOCI (433) — (433) Total OCI (519) — (519) Balance at September 30, 2021 $ 402 (1) $ (1) $ 401 (1) Includes nil of noncredit related impairments on securities and net unrealized gains (losses) on previously impaired securities as of both September 30, 2022 and 2021.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rate was 1.4% and 15.6% for the three months ended September 30, 2022 and 2021, respectively. The Company’s effective tax rate was 12.3% and 12.7% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate for the three months ended September 30, 2022 was lower than the statutory tax rate as a result of tax preferred items including low income housing tax credits, the dividends received deduction, and taxes applicable to prior years. The effective tax rate for the three months ended September 30,2021 was lower than the statutory tax rate as a result of tax preferred items including low income housing tax credits and the dividends received deduction. The effective tax rate for both the nine months ended September 30, 2022 and 2021 was lower than the statutory tax rate as a result of tax preferred items including low income housing tax credits, foreign tax credits, and the dividends received deduction. The decrease in the effective tax rate for the three months ended September 30, 2022 compared to the three months ended September 30, 2021 was primarily the result of lower pretax income. Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $9 million, net of federal benefit, which will expire beginning December 31, 2022. The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets of $2 million and state net operating losses of $9 million; therefore, a valuation allowance of $11 million has been established as of both September 30, 2022 and December 31, 2021. As of both September 30, 2022 and December 31, 2021, the Company had $37 million of gross unrecognized tax benefits. If recognized, approximately $20 million, net of federal tax benefits, of unrecognized tax benefits as of both September 30, 2022 and December 31, 2021 would affect the effective tax rate. It is reasonably possible that the total amount of unrecognized tax benefits will change in the next 12 months. The Company estimates that the total amount of gross unrecognized tax benefits may decrease by approximately $32 million in the next 12 months primarily due to Internal Revenue Service (“IRS”) settlements. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized nil in interest and penalties for the three and nine months ended September 30, 2022 and 2021. As of both September 30, 2022 and December 31, 2021, the Company had a payable of $3 million related to accrued interest and penalties. The Company files income tax returns as part of its inclusion in the consolidated federal income tax return of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. The federal statute of limitations are closed on years through 2015, except for one issue for 2014 and 2015 which was claimed on amended returns. The IRS is currently auditing Ameriprise Financial’s U.S. income tax returns for 2016 through 2020. Ameriprise Financial’s or its subsidiaries’, including the Company’s, state income tax returns are currently under examination by various jurisdictions for years ranging from 2015 through 2020.

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Contingencies The Company and its affiliates are involved in the normal course of business in legal proceedings which include regulatory inquiries, arbitration and litigation, including class actions, concerning matters arising in connection with the conduct of its activities. These include proceedings specific to the Company as well as proceedings generally applicable to business practices in the industries in which it operates. The Company can also be subject to legal proceedings arising out of its general business activities, such as its investments, contracts, and employment relationships. Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally. As with other insurance companies, the level of regulatory activity and inquiry concerning the Company’s businesses remains elevated. From time to time, the Company and its affiliates, including AFS and RiverSource Distributors, Inc. receive requests for information from, and/or are subject to examination or claims by various state, federal and other domestic authorities. The Company and its affiliates typically have numerous pending matters, which includes information requests, exams or inquiries regarding their business activities and practices and other subjects, including from time to time: sales and distribution of various products, including the Company’s life insurance and variable annuity products; supervision of associated persons, including AFS financial advisors and RiverSource Distributors Inc.’s wholesalers; administration of insurance and annuity claims; security of client information; and transaction monitoring systems and controls. The Company and its affiliates have cooperated and will continue to cooperate with the applicable regulators. These legal proceedings are subject to uncertainties and, as such, it is inherently difficult to determine whether any loss is probable or even reasonably possible, or to reasonably estimate the amount of any loss. The Company cannot predict with certainty if, how or when any such proceedings will be initiated or resolved. Matters frequently need to be more developed before a loss or range of loss can be reasonably estimated for any proceeding. An adverse outcome in one or more proceedings could eventually result in adverse judgments, settlements, fines, penalties or other sanctions, in addition to further claims, examinations or adverse publicity that could have a material adverse effect on the Company’s consolidated financial condition, results of operations or liquidity. In accordance with applicable accounting standards, the Company establishes an accrued liability for contingent litigation and regulatory matters when those matters present loss contingencies that are both probable and can be reasonably estimated. The Company discloses the nature of the contingency when management believes there is at least a reasonable possibility that the outcome may be material to the Company’s consolidated financial statements and, where feasible, an estimate of the possible loss. In such cases, there still may be an exposure to loss in excess of any amounts reasonably estimated and accrued. When a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability, but continues to monitor, in conjunction with any outside counsel handling a matter, further developments that would make such loss contingency both probable and reasonably estimable. Once the Company establishes an accrued liability with respect to a loss contingency, the Company continues to monitor the matter for further developments that could affect the amount of the accrued liability that has been previously established, and any appropriate adjustments are made each quarter. Guaranty Fund Assessments RiverSource Life Insurance Company and RiverSource Life of NY are required by law to be a member of the guaranty fund association in every state where they are licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations. The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated. The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. As of both September 30, 2022 and December 31, 2021, the estimated liability was $12 million. As of both September 30, 2022 and December 31, 2021, the related premium tax asset was $10 million. The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidation	The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest and variable interest entities (“VIEs”) in which it is the primary beneficiary (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation.
Basis of Accounting	The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year.
Future Adoption of New Accounting Standards	Future Adoption of New Accounting Standards Financial Instruments – Credit Losses – Troubled Debt Restructurings and Vintage Disclosures In March 2022, the Financial Accounting Standards Board (“FASB”) proposed amendments to Accounting Standard Update No. 2016-13, Financial Instruments—Credit Losses: Measurement of Credit Losses on Financial Instruments (“Topic 326”). The update removes the recognition and measurement guidance for Troubled Debt Restructurings (“TDRs”) by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, and modifies the disclosure requirements for certain loan refinancing and restructuring by creditors when a borrower is experiencing financial difficulty. Rather than applying the recognition and measurement for TDRs, an entity must apply the loan refinancing and restructuring guidance to determine whether a modification results in a new loan or a continuation of an existing loan. The update also requires entities to disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The amendments are to be applied prospectively, but entities may apply a modified retrospective transition for changes to the recognition and measurement of TDRs. For entities that have adopted Topic 326, the amendments are effective for interim and annual periods beginning after December 15, 2022. Early adoption is permitted for entities that have adopted Topic 326, including adoption in an interim period. The adoption of the standard is not expected to have a material impact on the Company’s consolidated financial condition and results of operations. Financial Services – Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts In August 2018, the FASB updated the accounting standard related to long-duration insurance contracts. The guidance revises elements of the measurement models and disclosure requirements for long-duration insurance contracts issued by insurers. Adoption of the accounting standard will not impact overall cash flows, insurance subsidiaries’ dividend capacity, or regulatory capital requirements. When the Company adopts the standard as of January 1, 2021 (the “transition date”), opening equity will be adjusted for the adoption impacts to retained earnings and accumulated other comprehensive income (loss) (“AOCI”) and prior periods presented (i.e. 2021 and 2022) will be restated. The Company has updated its estimated adoption impact as of January 1, 2021 to be a reduction in total equity of $1.8 billion to $2.1 billion, of which a significant portion will be reflected in AOCI. However, as of September 30, 2022, the impact on total equity is estimated to be an increase of $400 million to $600 million as a result of changes in the equity, credit, and rate environment subsequent to the transition date. The Company utilizes a governance framework to guide its adoption process and is managing a detailed implementation plan to support the timely application of the standard in the first quarter of 2023. The Company continues to refine its technology solutions and internal controls environment. These activities include, but are not limited to, modifications of actuarial valuation models, and accounting and financial reporting processes and systems. The estimated adoption impact at transition date and the impact to periods subsequent to transition date is subject to change as the Company completes its adoption process.

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of disaggregated revenue from contracts with customers	The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Policy and contract charges Affiliated $ 40 $ 50 $ 126 $ 144 Unaffiliated 3 4 11 12 Total 43 54 137 156 Other revenues Administrative fees Affiliated 10 13 32 37 Unaffiliated 5 5 14 15 15 18 46 52 Other fees Affiliated 80 99 258 291 Unaffiliated 1 1 3 4 81 100 261 295 Total 96 118 307 347 Total revenue from contracts with customers 139 172 444 503 Revenue from other sources (1) 746 223 2,375 1,956 Total revenues $ 885 $ 395 $ 2,819 $ 2,459

Variable Interest Entities (Tab

Variable Interest Entities (Tables) - Consolidated investment entities	9 Months Ended
	Sep. 30, 2022
Assets and liabilities measured at fair value
Schedule of balances of assets and liabilities measured at fair value on a recurring basis	The following tables present the balances of assets and liabilities held by consolidated investment entities measured at fair value on a recurring basis: September 30, 2022 Level 1 Level 2 Level 3 Total (in millions) Assets Investments: Corporate debt securities $ — $ 28 $ — $ 28 Common stocks — 3 — 3 Syndicated loans — 2,182 165 2,347 Total investments — 2,213 165 2,378 Receivables — 38 — 38 Other assets — 2 — 2 Total assets at fair value $ — $ 2,253 $ 165 $ 2,418 Liabilities Debt (1) $ — $ 2,401 $ — $ 2,401 Other liabilities — 161 — 161 Total liabilities at fair value $ — $ 2,562 $ — $ 2,562 December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Assets Investments: Common stocks $ — $ 3 $ — $ 3 Syndicated loans — 2,117 64 2,181 Total investments — 2,120 64 2,184 Receivables — 17 — 17 Other assets — — 3 3 Total assets at fair value $ — $ 2,137 $ 67 $ 2,204 Liabilities Debt (1) $ — $ 2,164 $ — $ 2,164 Other liabilities — 137 — 137 Total liabilities at fair value $ — $ 2,301 $ — $ 2,301
Summary of changes in Level 3 assets measured at fair value on a recurring basis	The following tables provide a summary of changes in Level 3 assets held by consolidated investment entities measured at fair value on a recurring basis: Common Stocks Syndicated Loans (in millions) Balance at July 1, 2022 $ 2 $ 95 Total gains (losses) included in: Net income — (4) (1) Purchases — 42 Sales — (3) Settlements — (1) Transfers into Level 3 — 61 Transfers out of Level 3 (2) (25) Balance at September 30, 2022 $ — $ 165 Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2022 $ — $ (5) (1) Syndicated Loans (in millions) Balance at July 1, 2021 $ 112 Purchases 7 Sales (4) Settlements (10) Transfers into Level 3 5 Transfers out of Level 3 (47) Deconsolidation of consolidated investment entities (18) Balance at September 30, 2021 $ 45 Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2021 $ — (1) Common Stocks Syndicated Loans Other Assets (in millions) Balance at January 1, 2022 $ — $ 64 $ 3 Total gains (losses) included in: Net income — (7) (1) — Purchases — 64 — Sales — (4) — Settlements — (8) — Transfers into Level 3 2 173 — Transfers out of Level 3 (2) (117) (3) Balance at September 30, 2022 $ — $ 165 $ — Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2022 $ — $ (5) (1) $ — Syndicated Loans Other Assets (in millions) Balance at January 1, 2021 $ 92 $ 2 Total gains (losses) included in: Net income 2 (1) — Purchases 88 — Sales (38) — Settlements (49) — Transfers into Level 3 90 — Transfers out of Level 3 (122) (2) Deconsolidation of consolidated investment entities (18) — Balance at September 30, 2021 $ 45 $ — Changes in unrealized gains (losses) included in net income relating to assets held at September 30, 2021 $ — (1) $ — (1) Included in Net investment income.
Schedule of fair value and unpaid principal balance of loans and debt for which fair value option has been elected	The following table presents the fair value and unpaid principal balance of loans and debt for which the fair value option has been elected: September 30, 2022 December 31, 2021 (in millions) Syndicated loans Unpaid principal balance $ 2,513 $ 2,233 Excess unpaid principal over fair value (166) (52) Fair value $ 2,347 $ 2,181 Fair value of loans more than 90 days past due $ — $ — Fair value of loans in nonaccrual status 17 13 Difference between fair value and unpaid principal of loans more than 90 days past due, loans in nonaccrual status or both 22 10 Debt Unpaid principal balance $ 2,638 $ 2,296 Excess unpaid principal over fair value (237) (132) Carrying value (1) $ 2,401 $ 2,164 (1) The carrying value of the CLOs’ debt is set equal to the fair value of the CLOs’ assets. The estimated fair value of the CLOs’ debt was $2.4 billion and $2.2 billion as of September 30, 2022 and December 31, 2021, respectively.
Schedule of debt and stated interest rates	Debt of the consolidated investment entities and the stated interest rates were as follows: Carrying Value Weighted Average Interest Rate September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) Debt of consolidated CLOs due 2028-2034 $ 2,401 $ 2,164 4.1 % 1.7 %

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-Sale securities by type	Available-for-Sale securities distributed by type were as follows: Description of Securities September 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value (in millions) Fixed maturities: Corporate debt securities $ 9,093 $ 125 $ (958) $ (20) $ 8,240 Residential mortgage backed securities 2,944 — (319) — 2,625 Commercial mortgage backed securities 3,056 — (258) — 2,798 State and municipal obligations 768 57 (26) (2) 797 Asset backed securities 908 11 (27) — 892 Foreign government bonds and obligations 39 — (3) — 36 U.S. government and agency obligations 1 — — — 1 Total $ 16,809 $ 193 $ (1,591) $ (22) $ 15,389 Description of Securities December 31, 2021 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value (in millions) Fixed maturities: Corporate debt securities $ 8,447 $ 1,238 $ (47) $ — $ 9,638 Residential mortgage backed securities 2,226 36 (12) — 2,250 Commercial mortgage backed securities 2,615 56 (15) — 2,656 State and municipal obligations 832 244 (1) (1) 1,074 Asset backed securities 517 22 (2) — 537 Foreign government bonds and obligations 80 4 (1) — 83 U.S. government and agency obligations 1 — — — 1 Total $ 14,718 $ 1,600 $ (78) $ (1) $ 16,239
Summary of fixed maturity securities by rating	A summary of fixed maturity securities by rating was as follows: Ratings September 30, 2022 December 31, 2021 Amortized Cost Fair Value Percent of Total Fair Value Amortized Cost Fair Value Percent of Total Fair Value (in millions, except percentages) AAA $ 6,199 $ 5,612 37 % $ 5,031 $ 5,107 31 % AA 1,071 1,111 7 757 932 6 A 1,443 1,438 9 1,662 2,013 12 BBB 7,431 6,635 43 6,293 7,063 44 Below investment grade (1) 665 593 4 975 1,124 7 Total fixed maturities $ 16,809 $ 15,389 100 % $ 14,718 $ 16,239 100 % (1) The amortized cost and fair value of below investment grade securities includes interest in non-consolidated CLOs managed by the Company of $1 million and $2 million, respectively, as of both September 30, 2022 and December 31, 2021. These securities are not rated but are included in below investment grade due to their risk characteristics.
Summary of fair value and gross unrealized losses on Available-for-Sale securities in continuous unrealized loss position	The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded: Description of Securities September 30, 2022 Less than 12 Months 12 Months or More Total Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 429 $ 5,438 $ (670) 70 $ 1,039 $ (288) 499 $ 6,477 $ (958) Residential mortgage backed securities 212 2,098 (204) 25 493 (115) 237 2,591 (319) Commercial mortgage backed securities 190 1,920 (187) 38 452 (71) 228 2,372 (258) State and municipal obligations 52 149 (17) 16 36 (9) 68 185 (26) Asset backed securities 36 779 (23) 2 31 (4) 38 810 (27) Foreign government bonds and obligations 11 32 (2) 1 1 (1) 12 33 (3) Total 930 $ 10,416 $ (1,103) 152 $ 2,052 $ (488) 1,082 $ 12,468 $ (1,591) Description of Securities December 31, 2021 Less than 12 Months 12 Months or More Total Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses Number of Securities Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 102 $ 2,007 $ (42) 14 $ 81 $ (5) 116 $ 2,088 $ (47) Residential mortgage backed securities 55 1,162 (12) 2 1 — 57 1,163 (12) Commercial mortgage backed securities 60 809 (15) 3 13 — 63 822 (15) State and municipal obligations 25 63 (1) — — — 25 63 (1) Asset backed securities 5 91 (2) — — — 5 91 (2) Foreign government bonds and obligations 5 6 — 6 4 (1) 11 10 (1) Total 252 $ 4,138 $ (72) 25 $ 99 $ (6) 277 $ 4,237 $ (78)
Rollforward of allowance for credit losses on Available-for-Sale securities	The following table presents a rollforward of the allowance for credit losses on Available-for-Sale securities: Corporate Debt Securities State and Municipal Obligations Total (in millions) Balance at July 1, 2022 $ — $ 1 $ 1 Additions for which credit losses were not previously recorded 20 — 20 Additional increases (decreases) on securities that had an allowance recorded in a previous period — 1 1 Balance at September 30, 2022 $ 20 $ 2 $ 22 Balance at July 1, 2021 $ — $ — $ — Additions for which credit losses were not previously recorded — 1 1 Balance at September 30, 2021 $ — $ 1 $ 1 Balance at January 1, 2022 $ — $ 1 $ 1 Additions for which credit losses were not previously recorded 20 — 20 Additional increases (decreases) on securities that had an allowance recorded in a previous period — 1 1 Balance at September 30, 2022 $ 20 $ 2 $ 22 Balance at January 1, 2021 $ 10 $ — $ 10 Additions for which credit losses were not previously recorded — 1 1 Charge-offs (10) — (10) Balance at September 30, 2021 $ — $ 1 $ 1
Schedule of net realized gains and losses on Available-for-Sale securities	Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in Net realized investment gains (losses) were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Gross realized investment gains $ 2 $ 505 $ 24 $ 568 Gross realized investment losses (6) (6) (20) (6) Credit losses (21) (1) (21) (1) Other impairments (61) — (67) (13) Total $ (86) $ 498 $ (84) $ 548
Schedule of Available-for-Sale securities by contractual maturity	Available-for-Sale securities by contractual maturity as of September 30, 2022 were as follows: Amortized Cost Fair Value (in millions) Due within one year $ 330 $ 328 Due after one year through five years 1,675 1,607 Due after five years through 10 years 3,661 3,085 Due after 10 years 4,235 4,054 9,901 9,074 Residential mortgage backed securities 2,944 2,625 Commercial mortgage backed securities 3,056 2,798 Asset backed securities 908 892 Total $ 16,809 $ 15,389
Summary of net investment income	The following is a summary of Net investment income: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in millions) Fixed maturities $ 156 $ 137 $ 435 $ 511 Mortgage loans 18 21 55 82 Other investments 55 40 92 86 229 198 582 679 Less: investment expenses 5 5 14 15 Total $ 224 $ 193 $ 568 $ 664

Financing Receivables (Tables)

Financing Receivables (Tables)	9 Months Ended
	Sep. 30, 2022
Financing Receivables
Rollforward of allowance for credit losses	The following tables present a rollforward of the allowance for credit losses: Commercial Loans (in millions) Balance at January 1, 2022 $ 12 Provisions (1) Balance at September 30, 2022 $ 11 Commercial Loans (in millions) Balance at January 1, 2021 $ 35 Provisions (21) Balance at September 30, 2021 $ 14
Schedule of concentrations of credit risk of loans by region and property type	Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: Loans Percentage September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) East North Central $ 199 $ 183 11 % 10 % East South Central 52 54 3 3 Middle Atlantic 95 107 5 6 Mountain 122 111 7 6 New England 17 21 1 1 Pacific 603 589 33 33 South Atlantic 484 477 27 26 West North Central 127 136 7 8 West South Central 116 122 6 7 1,815 1,800 100 % 100 % Less: allowance for credit losses 11 12 Total $ 1,804 $ 1,788 Concentrations of credit risk of commercial mortgage loans by property type were as follows: Loans Percentage September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 (in millions) Apartments $ 479 $ 464 26 % 26 % Hotel 14 15 1 1 Industrial 292 293 16 16 Mixed use 55 57 3 3 Office 250 254 14 14 Retail 593 589 33 33 Other 132 128 7 7 1,815 1,800 100 % 100 % Less: allowance for credit losses 11 12 Total $ 1,804 $ 1,788
Commercial Loans | Commercial mortgage loans
Financing Receivables
Schedule of amortized cost basis of loans and credit quality information	The tables below present the amortized cost basis of commercial mortgage loans by year of origination and loan-to-value ratio: September 30, 2022 Loan-to-Value Ratio 2022 2021 2020 2019 2018 Prior Total (in millions) > 100% $ — $ — $ 2 $ 2 $ — $ 39 $ 43 80% - 100% 1 9 2 20 8 47 87 60% - 80% 35 87 17 52 10 95 296 40% - 60% 40 84 65 80 55 432 756 < 40% 15 8 27 43 78 462 633 Total $ 91 $ 188 $ 113 $ 197 $ 151 $ 1,075 $ 1,815 December 31, 2021 Loan-to-Value Ratio 2021 2020 2019 2018 2017 Prior Total (in millions) > 100% $ — $ — $ 20 $ 10 $ — $ 29 $ 59 80% - 100% 9 2 9 2 — 29 51 60% - 80% 141 76 59 15 58 133 482 40% - 60% 37 30 75 74 49 393 658 < 40% 6 8 46 — 47 443 550 Total $ 193 $ 116 $ 209 $ 101 $ 154 $ 1,027 $ 1,800
Commercial Loans | Syndicated loans
Financing Receivables
Schedule of amortized cost basis of loans and credit quality information	The tables below present the amortized cost basis of syndicated loans by origination year and internal risk rating: September 30, 2022 Internal Risk Rating 2022 2021 2020 2019 2018 Prior Total (in millions) Risk 5 $ — $ — $ — $ — $ — $ — $ — Risk 4 — — — — — — — Risk 3 — 5 — 3 — 2 10 Risk 2 5 13 2 5 — 15 40 Risk 1 1 5 1 3 5 11 26 Total $ 6 $ 23 $ 3 $ 11 $ 5 $ 28 $ 76 December 31, 2021 Internal Risk Rating 2021 2020 2019 2018 2017 Prior Total (in millions) Risk 5 $ — $ — $ — $ — $ — $ — $ — Risk 4 — — — — — — — Risk 3 — — — — — 1 1 Risk 2 11 — 4 1 8 4 28 Risk 1 4 — — 3 3 4 14 Total $ 15 $ — $ 4 $ 4 $ 11 $ 9 $ 43

Deferred Acquisition Costs an_2

Deferred Acquisition Costs and Deferred Sales Inducement Costs (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Charges, Insurers [Abstract]
Schedule of balances of and changes in DAC	The balances of and changes in DAC were as follows: 2022 2021 (in millions) Balance at January 1 $ 2,757 $ 2,508 Capitalization of acquisition costs 146 196 Amortization (351) (129) Amortization, impact of valuation assumptions review 8 60 Impact of change in net unrealized (gains) losses on securities 420 75 Balance at September 30 $ 2,980 $ 2,710
Schedule of balances of and changes in DSIC	The balances of and changes in deferred sales inducement costs (“DSIC”), which is included in Other assets, were as follows: 2022 2021 (in millions) Balance at January 1 $ 187 $ 187 Capitalization of sales inducement costs 1 1 Amortization (34) (15) Amortization, impact of valuation assumptions review 2 2 Impact of change in net unrealized (gains) losses on securities 15 11 Balance at September 30 $ 171 $ 186

Policyholder Account Balances_2

Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities [Abstract]
Schedule of components of policyholder account balances, future policy benefits and claims	Policyholder account balances, future policy benefits and claims consisted of the following: September 30, 2022 December 31, 2021 (in millions) Policyholder account balances Fixed annuities (1) $ 7,776 $ 8,117 Variable annuity fixed sub-accounts 4,887 4,990 UL/VUL insurance 3,069 3,103 Indexed universal life (“IUL”) insurance 2,645 2,534 Structured variable annuities 5,314 4,440 Other life insurance 533 563 Total policyholder account balances 24,224 23,747 Future policy benefits Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) 2,101 2,336 Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (2) 64 (23) Other annuity liabilities 316 67 Fixed annuity life contingent liabilities 1,215 1,278 Life and disability income insurance 1,106 1,139 Long term care insurance 5,187 5,664 UL/VUL and other life insurance additional liabilities 1,048 1,291 Total future policy benefits 11,037 11,752 Policy claims and other policyholders’ funds 214 245 Total policyholder account balances, future policy benefits and claims $ 35,475 $ 35,744 (1) Includes fixed deferred annuities, non-life contingent fixed payout annuities and fixed deferred indexed annuity host contracts. (2) Includes the fair value of GMAB embedded derivatives that was a net asset as of December 31, 2021 and the amount is presented as a contra liability.
Schedule of components of separate account liabilities	Separate account liabilities consisted of the following: September 30, 2022 December 31, 2021 (in millions) Variable annuity $ 61,063 $ 82,862 VUL insurance 7,090 9,343 Other insurance 24 33 Total $ 68,177 $ 92,238

Variable Annuity and Insuranc_2

Variable Annuity and Insurance Guarantees (Tables)	9 Months Ended
	Sep. 30, 2022
Insurance [Abstract]
Schedule of variable annuity guarantees with additional liabilities	The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: Variable Annuity Guarantees by Benefit Type (1) September 30, 2022 December 31, 2021 Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age (in millions, except age) GMDB: Return of premium $ 51,949 $ 50,290 $ 1,440 69 $ 70,020 $ 68,145 $ 6 69 Five/six-year reset 6,652 3,986 277 69 8,309 5,612 6 68 One-year ratchet 4,612 4,306 1,019 72 6,177 5,858 13 71 Five-year ratchet 1,058 1,009 106 68 1,438 1,386 1 68 Other 964 950 284 75 1,302 1,286 38 74 Total — GMDB $ 65,235 $ 60,541 $ 3,126 69 $ 87,246 $ 82,287 $ 64 69 GGU death benefit $ 966 $ 909 $ 139 72 $ 1,260 $ 1,198 $ 184 72 GMIB $ 130 $ 117 $ 14 72 $ 184 $ 170 $ 4 71 GMWB: GMWB $ 1,351 $ 1,346 $ 54 75 $ 1,900 $ 1,895 $ 1 75 GMWB for life 37,871 37,865 3,090 70 52,387 52,334 187 69 Total — GMWB $ 39,222 $ 39,211 $ 3,144 70 $ 54,287 $ 54,229 $ 188 69 GMAB $ 1,391 $ 1,391 $ 187 62 $ 2,005 $ 2,005 $ — 62 (1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table.
Schedule insurance guarantees with additional liabilities	The following table provides information related to insurance guarantees for which the Company has established additional liabilities: September 30, 2022 December 31, 2021 Net Amount at Risk Weighted Average Attained Age Net Amount at Risk Weighted Average Attained Age (in millions, except age) UL secondary guarantees $ 6,496 69 $ 6,564 68 Structured variable annuity GMDB $ 723 64 $ 3 63
Schedule of changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees	Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: GMDB & GGU GMIB GMWB (1) GMAB (1) UL (in millions) Balance at January 1, 2022 $ 36 $ 5 $ 2,336 $ (23) $ 1,020 Incurred claims 40 2 (235) 87 87 Paid claims (15) — — — (31) Balance at September 30, 2022 $ 61 $ 7 $ 2,101 $ 64 $ 1,076 Balance at January 1, 2021 $ 24 $ 6 $ 3,049 $ 1 $ 916 Incurred claims 12 1 (793) (15) 106 Paid claims (3) (1) — — (27) Balance at September 30, 2021 $ 33 $ 6 $ 2,256 $ (14) $ 995 (1) The incurred claims for GMWB and GMAB include the change in the fair value of the liabilities (contra liabilities) less paid claims.
Summary of distribution of separate account balances by asset type	The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: September 30, 2022 December 31, 2021 (in millions) Mutual funds: Equity $ 38,594 $ 49,183 Bond 21,012 24,998 Other 6,224 8,316 Total mutual funds $ 65,830 $ 82,497

Fair Values of Assets and Lia_2

Fair Values of Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value of Assets and Liabilities
Summary of significant unobservable inputs used in fair value measurements of Level 3 assets and liabilities	The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: September 30, 2022 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 394 Discounted cash flow Yield/spread to U.S. Treasuries (1) 1.0% – 3.6% 1.5% Asset backed securities $ 556 Discounted cash flow Annual default rate 2.6% 2.6% Loss severity 25.0% 25.0% Yield/spread to U.S. Treasuries (2) 270 bps – 450 bps 277 bps Fixed deferred indexed annuity ceded embedded derivatives $ 47 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% IUL embedded derivatives $ 689 Discounted cash flow Nonperformance risk (4) 125 bps 125 bps Fixed deferred indexed annuity embedded derivatives $ 43 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% Nonperformance risk (4) 125 bps 125 bps GMWB and GMAB embedded derivatives $ 932 Discounted cash flow Utilization of guaranteed withdrawals (6) (7) 0.0% – 48.0% 10.9% Surrender rate (5) 0.1% – 55.7% 3.4% Market volatility (8) (9) 5.0% – 17.5% 12.1% Nonperformance risk (4) 125 bps 125 bps Structured variable annuity embedded derivatives $ (513) (10) Discounted cash flow Surrender rate (5) 0.8% – 40.0% 0.9% Nonperformance risk (4) 125 bps 125 bps December 31, 2021 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 496 Discounted cash flow Yield/spread to U.S. Treasuries (1) 0.8% – 2.4% 1.1% Asset backed securities $ 291 Discounted cash flow Annual default rate 5.8% 5.8% Loss severity 25.0% 25.0% Yield/spread to swap rates (3) 175 bps – 275 bps 182 bps Fixed deferred indexed annuity ceded embedded derivatives $ 59 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% IUL embedded derivatives $ 905 Discounted cash flow Nonperformance risk (4) 65 bps 65 bps Fixed deferred indexed annuity embedded derivatives $ 56 Discounted cash flow Surrender rate (5) 0.0% – 66.8% 1.4% Nonperformance risk (4) 65 bps 65 bps GMWB and GMAB embedded derivatives $ 1,486 Discounted cash flow Utilization of guaranteed withdrawals (6) (7) 0.0% – 48.0% 10.6% Surrender rate (5) 0.1% – 55.7% 3.6% Market volatility (8) (9) 4.3% – 16.8% 10.8% Nonperformance risk (4) 65 bps 65 bps Structured variable annuity embedded derivatives $ 406 Discounted cash flow Surrender rate (5) 0.8% – 40.0% 0.9% Nonperformance risk (4) 65 bps 65 bps (1) The weighted average for the spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities. (2) The weighted average for the spread to U.S. Treasuries for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to U.S. Treasuries divided by the aggregate balances of the tranches. (3) The weighted average for the spread to swap rates for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to swap divided by the aggregate balances of the tranches. (4) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. During the third quarter of 2022, the Company changed to using a U.S. Treasury curve as its observable discount rate curve reflecting the evolution of LIBOR discontinuation as an observable reference rate used by market participants. (5) The weighted average surrender rate is weighted based on the benefit base of each contract and represents the average assumption in the current year including the effect of a dynamic surrender formula. (6) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (7) The weighted average utilization rate represents the average assumption for the current year, weighting each policy evenly. The calculation excludes policies that have already started taking withdrawals. (8) Market volatility represents the implied volatility of fund of funds and managed volatility funds. (9) The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit. (10) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability.
Schedule of carrying value and estimated fair value of financial instruments not reported at fair value	The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value: September 30, 2022 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 1,804 $ — $ — $ 1,627 $ 1,627 Policy loans 838 — 838 — 838 Other investments 94 — 72 21 93 Receivables 7,528 — — 6,264 6,264 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 14,041 $ — $ — $ 12,048 $ 12,048 Short-term borrowings 201 — 201 — 201 Long-term debt 500 — 313 — 313 Other liabilities 8 — — 7 7 Separate account liabilities — investment contracts 288 — 288 — 288 December 31, 2021 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 1,788 $ — $ — $ 1,872 $ 1,872 Policy loans 834 — 834 — 834 Other investments 61 — 40 21 61 Receivables 7,876 — — 8,630 8,630 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 12,342 $ — $ — $ 13,264 $ 13,264 Short-term borrowings 200 — 200 — 200 Long-term debt 500 — 498 — 498 Other liabilities 9 — — 9 9 Separate account liabilities — investment contracts 403 — 403 — 403
RiverSource Life
Fair Value of Assets and Liabilities
Schedule of balances of assets and liabilities measured at fair value on a recurring basis	The following tables present the balances of assets and liabilities measured at fair value on a recurring basis (See Note 4 for the balances of assets and liabilities for consolidated investment entities): September 30, 2022 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Corporate debt securities $ — $ 7,846 $ 394 $ 8,240 Residential mortgage backed securities — 2,625 — 2,625 Commercial mortgage backed securities — 2,798 — 2,798 State and municipal obligations — 797 — 797 Asset backed securities — 336 556 892 Foreign government bonds and obligations — 36 — 36 U.S. government and agency obligations 1 — — 1 Total Available-for-Sale securities 1 14,438 950 15,389 Cash equivalents 1,155 1,318 — 2,473 Receivables: Fixed deferred indexed annuity ceded embedded derivatives — — 47 47 Other assets: Interest rate derivative contracts 15 362 — 377 Equity derivative contracts 137 2,519 — 2,656 Foreign exchange derivative contracts 1 88 — 89 Credit derivative contracts — 76 — 76 Total other assets 153 3,045 — 3,198 Separate account assets at net asset value (“NAV”) 68,177 (1) Total assets at fair value $ 1,309 $ 18,801 $ 997 $ 89,284 Liabilities Policyholder account balances, future policy benefits and claims: Fixed deferred indexed annuity embedded derivatives $ — $ 3 $ 43 $ 46 IUL embedded derivatives — — 689 689 GMWB and GMAB embedded derivatives — — 932 932 (2) Structured variable annuity embedded derivatives — — (513) (513) (3) Total policyholder account balances, future policy benefits and claims — 3 1,151 1,154 (4) Other liabilities: Interest rate derivative contracts 3 582 — 585 Equity derivative contracts 153 2,328 — 2,481 Foreign exchange derivative contracts 2 12 — 14 Total other liabilities 158 2,922 — 3,080 Total liabilities at fair value $ 158 $ 2,925 $ 1,151 $ 4,234 December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Corporate debt securities $ — $ 9,142 $ 496 $ 9,638 Residential mortgage backed securities — 2,250 — 2,250 Commercial mortgage backed securities — 2,656 — 2,656 State and municipal obligations — 1,074 — 1,074 Asset backed securities — 246 291 537 Foreign government bonds and obligations — 83 — 83 U.S. government and agency obligations 1 — — 1 Total Available-for-Sale securities 1 15,451 787 16,239 Cash equivalents 1,985 1,191 — 3,176 Receivables: Fixed deferred indexed annuity ceded embedded derivatives — — 59 59 Other assets: Interest rate derivative contracts 1 1,251 — 1,252 Equity derivative contracts 158 4,080 — 4,238 Foreign exchange derivative contracts 1 17 — 18 Credit derivative contracts — 9 — 9 Total other assets 160 5,357 — 5,517 Separate account assets at NAV 92,238 (1) Total assets at fair value $ 2,146 $ 21,999 $ 846 $ 117,229 Liabilities Policyholder account balances, future policy benefits and claims: Fixed deferred indexed annuity embedded derivatives $ — $ 5 $ 56 $ 61 IUL embedded derivatives — — 905 905 GMWB and GMAB embedded derivatives — — 1,486 1,486 (5) Structured variable annuity embedded derivatives — — 406 406 Total policyholder account balances, future policy benefits and claims — 5 2,853 2,858 (6) Other liabilities: Interest rate derivative contracts 1 467 — 468 Equity derivative contracts 101 3,610 — 3,711 Foreign exchange derivative contracts 1 — — 1 Total other liabilities 103 4,077 — 4,180 Total liabilities at fair value $ 103 $ 4,082 $ 2,853 $ 7,038 (1) Amounts are comprised of certain financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $1.2 billion of individual contracts in a liability position and $224 million of individual contracts in an asset position (recorded as a contra liability) as of September 30, 2022. ( 3 ) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability. (4) The Company’s adjustment for nonperformance risk resulted in a $778 million cumulative decrease to the embedded derivatives as of September 30, 2022. (5) The fair value of the GMWB and GMAB embedded derivatives included $1.6 billion of individual contracts in a liability position and $133 million of individual contracts in an asset position (recorded as a contra liability) as of December 31, 2021. (6) The Company’s adjustment for nonperformance risk resulted in a $598 million cumulative decrease to the embedded derivatives as of December 31, 2021.
Summary of changes in Level 3 assets measured at fair value on a recurring basis	The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Differed Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2022 $ 458 $ 236 $ 694 $ 49 Total gains (losses) included in: Net income — — — (2) Other comprehensive income (loss) (13) (3) (16) — Purchases 6 564 570 — Settlements (57) (241) (298) — Balance at September 30, 2022 $ 394 $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (13) $ (10) $ (23) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2022 $ 45 $ 719 $ 1,006 $ (362) (4) $ 1,408 Total (gains) losses included in: Net income (1) (2) (22) (2) (152) (3) (173) (3) (348) Issues — 18 89 19 126 Settlements (1) (26) (11) 3 (35) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (22) (2) $ (146) (3) $ (173) (3) $ (341) Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2021 $ 385 $ 336 $ 721 $ — Total gains (losses) included in: Net income (1) — (1) (1) — Other comprehensive income (loss) (3) — (3) — Purchases 9 — 9 — Issues — — — 57 Settlements (44) (20) (64) (1) Transfers into Level 3 168 2 170 — Balance at September 30, 2021 $ 514 $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ (4) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2021 $ 54 $ 928 $ 1,373 $ 214 $ 2,569 Total (gains) losses included in: Net income 1 (2) 14 (2) (69) (3) 17 (3) (37) Issues — — 95 (7) 88 Settlements (1) (25) 37 (7) 4 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 14 (2) $ (60) (3) $ — $ (46) Available-for-Sale Securities Receivables Corporate Debt Securities Commercial Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2022 $ 496 $ — $ 291 $ 787 $ 59 Total gains (losses) included in: Net income (1) — — (1) (1) (10) Other comprehensive income (loss) (46) — (14) (60) — Purchases 29 30 564 623 — Settlements (84) — (285) (369) (2) Transfers out of Level 3 — (30) — (30) — Balance at September 30, 2022 $ 394 $ — $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in net income relating to assets held at September 30, 2022 $ (1) $ — $ — $ (1) (1) $ — Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (45) $ — $ (10) $ (55) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2022 $ 56 $ 905 $ 1,486 $ 406 $ 2,853 Total (gains) losses included in: Net income (10) (2) (162) (2) (727) (3) (939) (3) (1,838) Issues — 26 260 37 323 Settlements (3) (80) (87) (17) (187) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (162) (2) $ (709) (3) $ (939) (3) $ (1,810) Available-for-Sale Securities Receivables Corporate Debt Securities Residential Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2021 $ 766 $ 9 $ 395 $ 1,170 $ — Total gains (losses) included in: Net income (1) — — (1) (1) — Other comprehensive income (loss) (6) — 3 (3) — Purchases 76 — — 76 — Issues — — — — 57 Settlements (73) — (58) (131) (1) Transfers into Level 3 168 — 2 170 — Transfers out of Level 3 (416) (9) (24) (449) — Balance at September 30, 2021 $ 514 $ — $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ 3 $ (1) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2021 $ 49 $ 935 $ 2,316 $ 70 $ 3,370 Total (gains) losses included in: Net income 7 (2) 51 (2) (1,273) (3) 192 (3) (1,023) Issues — 4 274 (22) 256 Settlements (2) (73) 119 (23) 21 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 51 (2) $ (1,236) (3) $ — $ (1,185) (1) Included in Net investment income. (2) Included in Interest credited to fixed accounts. (3) Included in Benefits, claims, losses and settlement expenses. (4) The fair value of the structured variable annuity embedded derivatives was a net asset as of both June 30, 2022 and September 30, 2022 and the amounts are presented as contra liabilities.
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis	The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Differed Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2022 $ 458 $ 236 $ 694 $ 49 Total gains (losses) included in: Net income — — — (2) Other comprehensive income (loss) (13) (3) (16) — Purchases 6 564 570 — Settlements (57) (241) (298) — Balance at September 30, 2022 $ 394 $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (13) $ (10) $ (23) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2022 $ 45 $ 719 $ 1,006 $ (362) (4) $ 1,408 Total (gains) losses included in: Net income (1) (2) (22) (2) (152) (3) (173) (3) (348) Issues — 18 89 19 126 Settlements (1) (26) (11) 3 (35) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (22) (2) $ (146) (3) $ (173) (3) $ (341) Available-for-Sale Securities Receivables Corporate Debt Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at July 1, 2021 $ 385 $ 336 $ 721 $ — Total gains (losses) included in: Net income (1) — (1) (1) — Other comprehensive income (loss) (3) — (3) — Purchases 9 — 9 — Issues — — — 57 Settlements (44) (20) (64) (1) Transfers into Level 3 168 2 170 — Balance at September 30, 2021 $ 514 $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ (4) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at July 1, 2021 $ 54 $ 928 $ 1,373 $ 214 $ 2,569 Total (gains) losses included in: Net income 1 (2) 14 (2) (69) (3) 17 (3) (37) Issues — — 95 (7) 88 Settlements (1) (25) 37 (7) 4 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 14 (2) $ (60) (3) $ — $ (46) Available-for-Sale Securities Receivables Corporate Debt Securities Commercial Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2022 $ 496 $ — $ 291 $ 787 $ 59 Total gains (losses) included in: Net income (1) — — (1) (1) (10) Other comprehensive income (loss) (46) — (14) (60) — Purchases 29 30 564 623 — Settlements (84) — (285) (369) (2) Transfers out of Level 3 — (30) — (30) — Balance at September 30, 2022 $ 394 $ — $ 556 $ 950 $ 47 Changes in unrealized gains (losses) in net income relating to assets held at September 30, 2022 $ (1) $ — $ — $ (1) (1) $ — Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2022 $ (45) $ — $ (10) $ (55) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2022 $ 56 $ 905 $ 1,486 $ 406 $ 2,853 Total (gains) losses included in: Net income (10) (2) (162) (2) (727) (3) (939) (3) (1,838) Issues — 26 260 37 323 Settlements (3) (80) (87) (17) (187) Balance at September 30, 2022 $ 43 $ 689 $ 932 $ (513) (4) $ 1,151 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2022 $ — $ (162) (2) $ (709) (3) $ (939) (3) $ (1,810) Available-for-Sale Securities Receivables Corporate Debt Securities Residential Mortgage Backed Securities Asset Backed Securities Total Fixed Deferred Indexed Annuity Ceded Embedded Derivatives (in millions) Balance at January 1, 2021 $ 766 $ 9 $ 395 $ 1,170 $ — Total gains (losses) included in: Net income (1) — — (1) (1) — Other comprehensive income (loss) (6) — 3 (3) — Purchases 76 — — 76 — Issues — — — — 57 Settlements (73) — (58) (131) (1) Transfers into Level 3 168 — 2 170 — Transfers out of Level 3 (416) (9) (24) (449) — Balance at September 30, 2021 $ 514 $ — $ 318 $ 832 $ 56 Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at September 30, 2021 $ (4) $ — $ 3 $ (1) $ — Policyholder Account Balances, Future Policy Benefits and Claims Fixed Deferred Indexed Annuity Embedded Derivatives IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Structured Variable Annuity Embedded Derivatives Total (in millions) Balance at January 1, 2021 $ 49 $ 935 $ 2,316 $ 70 $ 3,370 Total (gains) losses included in: Net income 7 (2) 51 (2) (1,273) (3) 192 (3) (1,023) Issues — 4 274 (22) 256 Settlements (2) (73) 119 (23) 21 Balance at September 30, 2021 $ 54 $ 917 $ 1,436 $ 217 $ 2,624 Changes in unrealized (gains) losses in net income relating to liabilities held at September 30, 2021 $ — $ 51 (2) $ (1,236) (3) $ — $ (1,185) (1) Included in Net investment income. (2) Included in Interest credited to fixed accounts. (3) Included in Benefits, claims, losses and settlement expenses. (4) The fair value of the structured variable annuity embedded derivatives was a net asset as of both June 30, 2022 and September 30, 2022 and the amounts are presented as contra liabilities.

Offsetting Assets and Liabili_2

Offsetting Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Offsetting [Abstract]
Schedule of gross and net information about assets subject to master netting arrangements	The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: September 30, 2022 Gross Amounts of Recognized Assets Gross Amounts Offset in the Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,975 $ — $ 2,975 $ (2,386) $ (552) $ (7) $ 30 OTC cleared 105 — 105 (105) — — — Exchange-traded 118 — 118 (79) — — 39 Total derivatives $ 3,198 $ — $ 3,198 $ (2,570) $ (552) $ (7) $ 69 December 31, 2021 Gross Amounts of Recognized Assets Gross Amounts Offset in the Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 5,330 $ — $ 5,330 $ (3,571) $ (1,623) $ (114) $ 22 OTC cleared 88 — 88 (41) — — 47 Exchange-traded 99 — 99 (91) — — 8 Total derivatives $ 5,517 $ — $ 5,517 $ (3,703) $ (1,623) $ (114) $ 77 (1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.
Schedule of gross and net information about liabilities subject to master netting arrangements	The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: September 30, 2022 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,791 $ — $ 2,791 $ (2,386) $ (70) $ (322) $ 13 OTC cleared 201 — 201 (105) — — 96 Exchange-traded 88 — 88 (79) — (9) — Total derivatives $ 3,080 $ — $ 3,080 $ (2,570) $ (70) $ (331) $ 109 December 31, 2021 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset in the Consolidated Balance Sheets Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 4,048 $ — $ 4,048 $ (3,571) $ (181) $ (293) $ 3 OTC cleared 41 — 41 (41) — — — Exchange-traded 91 — 91 (91) — — — Total derivatives $ 4,180 $ — $ 4,180 $ (3,703) $ (181) $ (293) $ 3 (1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.

Derivatives and Hedging Activ_2

Derivatives and Hedging Activities (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of notional value and gross fair value of derivative instruments, including embedded derivatives	Generally, the Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives: September 30, 2022 December 31, 2021 Notional Gross Fair Value Notional Gross Fair Value Assets (1) Liabilities (2)(3) Assets (1) Liabilities (2)(3) (in millions) Derivatives not designated as hedging instruments Interest rate contracts $ 95,693 $ 377 $ 585 $ 79,459 $ 1,252 $ 468 Equity contracts 67,418 2,656 2,481 59,763 4,238 3,711 Credit contracts 1,684 76 — 1,717 9 — Foreign exchange contracts 2,516 89 14 2,239 18 1 Total non-designated hedges 167,311 3,198 3,080 143,178 5,517 4,180 Embedded derivatives GMWB and GMAB (4) N/A — 932 N/A — 1,486 IUL N/A — 689 N/A — 905 Fixed deferred indexed annuities and deposit receivables N/A 47 46 N/A 59 61 Structured variable annuities (5) N/A — (513) N/A — 406 Total embedded derivatives N/A 47 1,154 N/A 59 2,858 Total derivatives $ 167,311 $ 3,245 $ 4,234 $ 143,178 $ 5,576 $ 7,038 N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets and the fair value of ceded embedded derivative assets related to deposit receivables is included in Receivables. (2) The fair value of freestanding derivative liabilities is included in Other liabilities. The fair value of GMWB and GMAB, IUL, fixed deferred indexed annuity and structured variable annuity embedded derivatives is included in Policyholder account balances, future policy benefits and claims. (3) The fair value of the Company’s derivative liabilities after considering the effects of master netting arrangements, cash collateral held by the same counterparty and the fair value of net embedded derivatives was $1.6 billion and $3.2 billion as of September 30, 2022 and December 31, 2021, respectively. See Note 12 for additional information related to master netting arrangements and cash collateral. (4) The fair value of the GMWB and GMAB embedded derivatives as of September 30, 2022 included $1.2 billion of individual contracts in a liability position and $224 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2021 included $1.6 billion of individual contracts in a liability position and $133 million of individual contracts in an asset position. (5) The fair value of the structured variable annuity embedded derivatives was a net asset as of September 30, 2022 and the amount is presented as a contra liability.
Summary of impact of derivatives not designated as hedging instruments, including embedded derivatives	The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income: Net Investment Income Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended September 30, 2022 Interest rate contracts $ — $ — $ (753) Equity contracts — (23) 341 Credit contracts — — 92 Foreign exchange contracts — — 112 GMWB and GMAB embedded derivatives — — 71 IUL embedded derivatives — 48 — Structured variable annuity embedded derivatives — — 173 Total gain (loss) $ — $ 25 $ 36 Three Months Ended September 30, 2021 Interest rate contracts $ — $ — $ (171) Equity contracts — — 1 Credit contracts — — 2 GMWB and GMAB embedded derivatives — — (64) IUL embedded derivatives — 11 — Fixed deferred indexed annuity embedded derivatives — 1 — Structured variable annuity embedded derivatives — — (17) Total gain (loss) $ — $ 12 $ (249) Net Investment Income Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Nine Months Ended September 30, 2022 Interest rate contracts $ — $ — $ (2,815) Equity contracts — (135) 1,066 Credit contracts — — 288 Foreign exchange contracts — — 219 GMWB and GMAB embedded derivatives — — 551 IUL embedded derivatives — 242 — Fixed deferred indexed annuity and deposit receivables embedded derivatives — 3 — Structured variable annuity embedded derivatives — — 939 Total gain (loss) $ — $ 110 $ 248 Nine Months Ended September 30, 2021 Interest rate contracts $ — $ — $ (1,125) Equity contracts 1 55 (613) Credit contracts — — 41 Foreign exchange contracts — — 6 GMWB and GMAB embedded derivatives — — 879 IUL embedded derivatives — 22 — Fixed deferred indexed annuity embedded derivatives — (7) — Structured variable annuity embedded derivatives — — (192) Total gain (loss) $ 1 $ 70 $ (1,004)
Summary of payments to make and receive for options and swaptions	The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of September 30, 2022: Premiums Payable Premiums Receivable (in millions) 2022 (1) $ 37 $ 62 2023 50 43 2024 130 23 2025 118 20 2026 249 88 2027 - 2029 77 — Total $ 661 $ 236 (1) 2022 amounts represent the amounts payable and receivable for the period from October 1, 2022 to December 31, 2022.

Shareholder's Equity (Tables)

Shareholder's Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of amounts related to each component of OCI	The following tables provide the amounts related to each component of OCI: Three Months Ended September 30, 2022 2021 Pretax Income Tax Benefit (Expense) Net of Tax Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized gains (losses) on securities: Net unrealized gains (losses) on securities arising during the period (1) $ (842) $ 178 $ (664) $ (57) $ 14 $ (43) Reclassification of net (gains) losses on securities included in net income (2) 86 (19) 67 (498) 104 (394) Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables 219 (46) 173 147 (31) 116 Net unrealized gains (losses) on securities (537) 113 (424) (408) 87 (321) Total other comprehensive income (loss) $ (537) $ 113 $ (424) $ (408) $ 87 $ (321) Nine Months Ended September 30, 2022 2021 Pretax Income Tax Benefit (Expense) Net of Tax Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized gains (losses) on securities: Net unrealized gains (losses) on securities arising during the period (1) $ (3,004) $ 639 $ (2,365) $ (396) $ 86 $ (310) Reclassification of net (gains) losses on securities included in net income (2) 84 (18) 66 (548) 115 (433) Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables 1,145 (240) 905 284 (60) 224 Net unrealized gains (losses) on securities (1,775) 381 (1,394) (660) 141 (519) Total other comprehensive income (loss) $ (1,775) $ 381 $ (1,394) $ (660) $ 141 $ (519) (1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period. (2) Reclassification amounts are recorded in Net realized investment gains (losses).
Schedule of changes in the balances of each component of AOCI	The following table presents the changes in the balances of each component of AOCI, net of tax: Net Unrealized Gains (Losses) on Securities Other Total (in millions) Balance at July 1, 2022 $ (641) $ (1) $ (642) OCI before reclassifications (491) — (491) Amounts reclassified from AOCI 67 — 67 Total OCI (424) — (424) Balance at September 30, 2022 $ (1,065) $ (1) $ (1,066) Balance at July 1, 2021 $ 723 $ (1) $ 722 OCI before reclassifications 73 — 73 Amounts reclassified from AOCI (394) — (394) Total OCI (321) — (321) Balance at September 30, 2021 $ 402 $ (1) $ 401 Balance at January 1, 2022 $ 329 $ (1) $ 328 OCI before reclassifications (1,460) — (1,460) Amounts reclassified from AOCI 66 — 66 Total OCI (1,394) — (1,394) Balance at September 30, 2022 $ (1,065) (1) $ (1) $ (1,066) Balance at January 1, 2021 $ 921 $ (1) $ 920 OCI before reclassifications (86) — (86) Amounts reclassified from AOCI (433) — (433) Total OCI (519) — (519) Balance at September 30, 2021 $ 402 (1) $ (1) $ 401 (1) Includes nil of noncredit related impairments on securities and net unrealized gains (losses) on previously impaired securities as of both September 30, 2022 and 2021.

Basis of Presentation (Details)

Basis of Presentation (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) subsidiary	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) subsidiary	Sep. 30, 2021 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of wholly owned subsidiaries | subsidiary	1		1
Out-of-period correction
Other comprehensive income (loss), net of tax	$ (424)	$ (321)	$ (1,394)	$ (519)
Correction Related to Other Comprehensive Income
Out-of-period correction
Other comprehensive income (loss), net of tax			$ 256

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Jan. 01, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 586	$ 1,059	$ 1,885	$ 1,959	$ 2,602		$ 3,313
Cumulative Effect, Period of Adoption, Adjustment | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	400					$ (1,800)
Cumulative Effect, Period of Adoption, Adjustment | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 600					$ (2,100)

Revenue from Contract with Cust

Revenue from Contract with Customers - Disaggregated Revenue and Receivables (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues
Revenue from contracts with customers	$ 139	$ 172	$ 444	$ 503
Revenue from other sources	746	223	2,375	1,956
Total revenues	885	395	2,819	2,459
Receivables related to revenues from contracts with customers	49		49		$ 62
Policy and contract charges
Revenues
Revenue from contracts with customers	43	54	137	156
Policy and contract charges | Affiliated
Revenues
Revenue from contracts with customers	40	50	126	144
Policy and contract charges | Unaffiliated
Revenues
Revenue from contracts with customers	3	4	11	12
Total Other revenues
Revenues
Revenue from contracts with customers	96	118	307	347
Other revenues: Administrative fees
Revenues
Revenue from contracts with customers	15	18	46	52
Other revenues: Administrative fees | Affiliated
Revenues
Revenue from contracts with customers	10	13	32	37
Other revenues: Administrative fees | Unaffiliated
Revenues
Revenue from contracts with customers	5	5	14	15
Other revenues: Other fees
Revenues
Revenue from contracts with customers	81	100	261	295
Other revenues: Other fees | Affiliated
Revenues
Revenue from contracts with customers	80	99	258	291
Other revenues: Other fees | Unaffiliated
Revenues
Revenue from contracts with customers	$ 1	$ 1	$ 3	$ 4

Variable Interest Entities - In

Variable Interest Entities - Investment Entities (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
VIEs, not primary beneficiary
Variable interest entities
Obligation to provide financial or other support to VIEs	$ 0
VIEs, not primary beneficiary | Affordable Housing Partnerships and Other Real Estate Partnerships
Variable interest entities
Maximum loss exposure	105	$ 138
Other investments	105	138
Liability related to original purchase commitments not yet remitted	7	8
VIEs, not primary beneficiary | CLOs
Variable interest entities
Available-for-Sale: Fixed maturities, amortized cost	1	1
Maximum loss exposure	1	1
Consolidated investment entities | Unfunded commitments
Variable interest entities
Loans	$ 28	$ 27

Variable Interest Entities - Fa

Variable Interest Entities - Fair Value of Assets and Liabilities (Details) - Consolidated investment entities - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Liabilities
Debt	$ 2,401	$ 2,164
Recurring basis
Assets
Investments	2,378	2,184
Receivables	38	17
Other assets	2	3
Total assets at fair value	2,418	2,204
Liabilities
Debt	2,401	2,164
Other liabilities	161	137
Total liabilities at fair value	2,562	2,301
Recurring basis | Corporate debt securities
Assets
Investments	28
Recurring basis | Common stocks
Assets
Investments	3	3
Recurring basis | Syndicated loans
Assets
Investments	2,347	2,181
Recurring basis | Level 1
Assets
Investments	0	0
Receivables	0	0
Other assets	0	0
Total assets at fair value	0	0
Liabilities
Debt	0	0
Other liabilities	0	0
Total liabilities at fair value	0	0
Recurring basis | Level 1 | Corporate debt securities
Assets
Investments	0
Recurring basis | Level 1 | Common stocks
Assets
Investments	0	0
Recurring basis | Level 1 | Syndicated loans
Assets
Investments	0	0
Recurring basis | Level 2
Assets
Investments	2,213	2,120
Receivables	38	17
Other assets	2	0
Total assets at fair value	2,253	2,137
Liabilities
Debt	2,401	2,164
Other liabilities	161	137
Total liabilities at fair value	2,562	2,301
Recurring basis | Level 2 | Corporate debt securities
Assets
Investments	28
Recurring basis | Level 2 | Common stocks
Assets
Investments	3	3
Recurring basis | Level 2 | Syndicated loans
Assets
Investments	2,182	2,117
Recurring basis | Level 3
Assets
Investments	165	64
Receivables	0	0
Other assets	0	3
Total assets at fair value	165	67
Liabilities
Debt	0	0
Other liabilities	0	0
Total liabilities at fair value	0	0
Recurring basis | Level 3 | Corporate debt securities
Assets
Investments	0
Recurring basis | Level 3 | Common stocks
Assets
Investments	0	0
Recurring basis | Level 3 | Syndicated loans
Assets
Investments	165	64
CLOs
Liabilities
Debt	$ 2,400	$ 2,200

Variable Interest Entities - Ch

Variable Interest Entities - Changes in Level 3 Assets (Details) - Consolidated investment entities - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Common stocks
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	$ 2		$ 0
Total gains (losses) included in net income	0		0
Purchases	0		0
Sales	0		0
Settlements	0		0
Transfers into level 3	0		2
Transfers out of Level 3	(2)		(2)
Balance, ending	0		0
Changes in unrealized gains (losses) in net income relating to assets held at end of period	0		0
Syndicated loans
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	95	$ 112	64	$ 92
Total gains (losses) included in net income	(4)		(7)	2
Purchases	42	7	64	88
Sales	(3)	(4)	(4)	(38)
Settlements	(1)	(10)	(8)	(49)
Transfers into level 3	61	5	173	90
Transfers out of Level 3	(25)	(47)	(117)	(122)
Deconsolidation of consolidated investment entities		(18)		(18)
Balance, ending	165	45	165	45
Changes in unrealized gains (losses) in net income relating to assets held at end of period	(5)	0	(5)	0
Other assets
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning			3	2
Total gains (losses) included in net income			0	0
Purchases			0	0
Sales			0	0
Settlements			0	0
Transfers into level 3			0	0
Transfers out of Level 3			(3)	(2)
Deconsolidation of consolidated investment entities				0
Balance, ending	$ 0	$ 0	0	0
Changes in unrealized gains (losses) in net income relating to assets held at end of period			$ 0	$ 0

Variable Interest Entities - _2

Variable Interest Entities - Fair Value Option (Details) - Consolidated investment entities - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Loans
Unpaid principal balance	$ 2,513	$ 2,233
Excess unpaid principal over fair value	(166)	(52)
Fair Value	2,347	2,181
Fair value of loans more than 90 days past due	0	0
Fair value of loans in nonaccrual status	17	13
Difference between fair value and unpaid principal of loans more than 90 days past due, loans in nonaccrual status or both	22	10
Debt
Unpaid principal balance	2,638	2,296
Excess unpaid principal over fair value	(237)	(132)
Carrying value	2,401	2,164
CLOs
Debt
Carrying value	$ 2,400	$ 2,200

Variable Interest Entities - Na

Variable Interest Entities - Narrative (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($) cLO
Variable interest entities
Number of new CLOs | cLO	1
Consolidated investment entities
Variable interest entities
Debt issued | $	$ 352

Variable Interest Entities - De

Variable Interest Entities - Debt and Stated Interest Rates (Details) - Consolidated investment entities - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt
Carrying value	$ 2,401	$ 2,164
Weighted Average Interest Rate	4.10%	1.70%
Minimum
Debt
Interest rates	0%
Maximum
Debt
Interest rates	12%

Investments - Available-for-Sal

Investments - Available-for-Sale Securities by Type (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Investments
Securities invested		$ 4,235	$ 2,680
RiverSource Life
Investments
Amortized Cost	$ 16,809	16,809			$ 14,718
Gross Unrealized Gains	193	193			1,600
Gross Unrealized Losses	(1,591)	(1,591)			(78)
Allowance for Credit Losses	(22)	(22)	(1)	$ (1)	(1)	$ 0	$ (10)
Fair Value	15,389	15,389			16,239
Accrued interest excluded from amortized cost basis	139	139			118
RiverSource Life | Assets pledged to meet contractual obligations
Investments
Fair Value	3,000	3,000			2,400
RiverSource Life | Assets pledged to meet contractual obligations, which may be sold, pledged or rehypothecated by the counterparty
Investments
Fair Value	373	373			314
RiverSource Life | Corporate debt securities
Investments
Amortized Cost	9,093	9,093			8,447
Gross Unrealized Gains	125	125			1,238
Gross Unrealized Losses	(958)	(958)			(47)
Allowance for Credit Losses	(20)	(20)	0	0	0	0	(10)
Fair Value	8,240	8,240			9,638
RiverSource Life | Residential mortgage backed securities
Investments
Amortized Cost	2,944	2,944			2,226
Gross Unrealized Gains	0	0			36
Gross Unrealized Losses	(319)	(319)			(12)
Allowance for Credit Losses	0	0			0
Fair Value	2,625	2,625			2,250
RiverSource Life | Commercial mortgage backed securities
Investments
Amortized Cost	3,056	3,056			2,615
Gross Unrealized Gains	0	0			56
Gross Unrealized Losses	(258)	(258)			(15)
Allowance for Credit Losses	0	0			0
Fair Value	2,798	2,798			2,656
RiverSource Life | State and municipal obligations
Investments
Amortized Cost	768	768			832
Gross Unrealized Gains	57	57			244
Gross Unrealized Losses	(26)	(26)			(1)
Allowance for Credit Losses	(2)	(2)	$ (1)	$ (1)	(1)	$ 0	$ 0
Fair Value	797	797			1,074
RiverSource Life | Asset backed securities
Investments
Amortized Cost	908	908			517
Gross Unrealized Gains	11	11			22
Gross Unrealized Losses	(27)	(27)			(2)
Allowance for Credit Losses	0	0			0
Fair Value	892	892			537
RiverSource Life | Asset backed securities | Affiliated [Member]
Investments
Fair Value	555	555			289
Securities invested	564
RiverSource Life | Foreign government bonds and obligations
Investments
Amortized Cost	39	39			80
Gross Unrealized Gains	0	0			4
Gross Unrealized Losses	(3)	(3)			(1)
Allowance for Credit Losses	0	0			0
Fair Value	36	36			83
RiverSource Life | U.S. government and agency obligations
Investments
Amortized Cost	1	1			1
Gross Unrealized Gains	0	0			0
Gross Unrealized Losses	0	0			0
Allowance for Credit Losses	0	0			0
Fair Value	$ 1	$ 1			$ 1

Investments - Summary of Fixed

Investments - Summary of Fixed Maturity Securities by Rating and Concentrations of Risk (Details) - RiverSource Life $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) issuer	Dec. 31, 2021 USD ($) issuer
Investments
Fixed maturity securities rated internally	$ 256	$ 359
Amortized Cost	16,809	14,718
Fair Value	15,389	16,239
AAA
Investments
Amortized Cost	6,199	5,031
Fair Value	5,612	5,107
AA
Investments
Amortized Cost	1,071	757
Fair Value	1,111	932
A
Investments
Amortized Cost	1,443	1,662
Fair Value	1,438	2,013
BBB
Investments
Amortized Cost	7,431	6,293
Fair Value	6,635	7,063
Below investment grade
Investments
Amortized Cost	665	975
Fair Value	593	1,124
Below investment grade | CLOs
Investments
Amortized Cost	1	1
Fair Value	2	2
Asset backed securities
Investments
Amortized Cost	908	517
Fair Value	$ 892	$ 537
Investment concentration risk | Credit concentration risk | Fixed maturities
Investments
Percentage of total	84%	85%
Fixed maturity securities | Credit concentration risk
Investments
Percentage of total	100%	100%
Fixed maturity securities | Credit concentration risk | AAA
Investments
Percentage of total	37%	31%
Fixed maturity securities | Credit concentration risk | AA
Investments
Percentage of total	7%	6%
Fixed maturity securities | Credit concentration risk | A
Investments
Percentage of total	9%	12%
Fixed maturity securities | Credit concentration risk | BBB
Investments
Percentage of total	43%	44%
Fixed maturity securities | Credit concentration risk | Below investment grade
Investments
Percentage of total	4%	7%
Fixed maturity securities | Credit concentration risk | GNMA, FNMA and FHLMC mortgage backed securities | AAA
Investments
Percentage of total	36%	40%
Shareholders' equity | Investment concentration risk
Investments
Number of issuers greater than 10% of equity | issuer	59	4
Issuers greater than 10% of equity	$ 6,300	$ 903
Shareholders' equity | Investment concentration risk | Maximum
Investments
Percentage of total	33%	14%
Shareholders' equity | Investment concentration risk | Minimum
Investments
Percentage of total	10%	10%
Shareholders' equity | Investment concentration risk | AAF 2
Investments
Percentage of total	95%	16%
Issuers greater than 10% of equity	$ 555	$ 289

Investments - Available-for Sal

Investments - Available-for Sale Securities in Continuous Unrealized Loss Position (Details) - RiverSource Life $ in Millions	Sep. 30, 2022 USD ($) security	Dec. 31, 2021 USD ($) security
Number of Securities
Less than 12 months | security	930	252
12 months or more | security	152	25
Total | security	1,082	277
Fair Value
Less than 12 months	$ 10,416	$ 4,138
12 months or more	2,052	99
Total	12,468	4,237
Unrealized Losses
Less than 12 months	(1,103)	(72)
12 months or more	(488)	(6)
Total	$ (1,591)	$ (78)
Available -for-Sale Securities with gross unrealized losses considered investment grade (as a percent)	93%	92%
Corporate debt securities
Number of Securities
Less than 12 months | security	429	102
12 months or more | security	70	14
Total | security	499	116
Fair Value
Less than 12 months	$ 5,438	$ 2,007
12 months or more	1,039	81
Total	6,477	2,088
Unrealized Losses
Less than 12 months	(670)	(42)
12 months or more	(288)	(5)
Total	$ (958)	$ (47)
Residential mortgage backed securities
Number of Securities
Less than 12 months | security	212	55
12 months or more | security	25	2
Total | security	237	57
Fair Value
Less than 12 months	$ 2,098	$ 1,162
12 months or more	493	1
Total	2,591	1,163
Unrealized Losses
Less than 12 months	(204)	(12)
12 months or more	(115)	0
Total	$ (319)	$ (12)
Commercial mortgage backed securities
Number of Securities
Less than 12 months | security	190	60
12 months or more | security	38	3
Total | security	228	63
Fair Value
Less than 12 months	$ 1,920	$ 809
12 months or more	452	13
Total	2,372	822
Unrealized Losses
Less than 12 months	(187)	(15)
12 months or more	(71)	0
Total	$ (258)	$ (15)
State and municipal obligations
Number of Securities
Less than 12 months | security	52	25
12 months or more | security	16	0
Total | security	68	25
Fair Value
Less than 12 months	$ 149	$ 63
12 months or more	36	0
Total	185	63
Unrealized Losses
Less than 12 months	(17)	(1)
12 months or more	(9)	0
Total	$ (26)	$ (1)
Asset backed securities
Number of Securities
Less than 12 months | security	36	5
12 months or more | security	2	0
Total | security	38	5
Fair Value
Less than 12 months	$ 779	$ 91
12 months or more	31	0
Total	810	91
Unrealized Losses
Less than 12 months	(23)	(2)
12 months or more	(4)	0
Total	$ (27)	$ (2)
Foreign government bonds and obligations
Number of Securities
Less than 12 months | security	11	5
12 months or more | security	1	6
Total | security	12	11
Fair Value
Less than 12 months	$ 32	$ 6
12 months or more	1	4
Total	33	10
Unrealized Losses
Less than 12 months	(2)	0
12 months or more	(1)	(1)
Total	$ (3)	$ (1)

Investments - Rollforward of Al

Investments - Rollforward of Allowance for Credit Losses (Details) - RiverSource Life - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Rollforward of available-for-Sale securities allowance for credit losses
Beginning balance	$ 1	$ 0	$ 1	$ 10
Additions for which credit losses were not previously recorded	20	1	20	1
Additional increases (decreases) on securities that had an allowance recorded in a previous period	1		1
Charge-offs				(10)
Ending balance	22	1	22	1
Corporate debt securities
Rollforward of available-for-Sale securities allowance for credit losses
Beginning balance	0	0	0	10
Additions for which credit losses were not previously recorded	20	0	20	0
Additional increases (decreases) on securities that had an allowance recorded in a previous period	0		0
Charge-offs				(10)
Ending balance	20	0	20	0
State and municipal obligations
Rollforward of available-for-Sale securities allowance for credit losses
Beginning balance	1	0	1	0
Additions for which credit losses were not previously recorded	0	1	0	1
Additional increases (decreases) on securities that had an allowance recorded in a previous period	1		1
Charge-offs				0
Ending balance	$ 2	$ 1	$ 2	$ 1

Investments - Net Realized Gain

Investments - Net Realized Gains and Losses on Available-for-Sale Securities (Details) - RiverSource Life - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net realized gains and losses on Available-for-Sale securities,
Gross realized investment gains	$ 2	$ 505	$ 24	$ 568
Gross realized investment losses	(6)	(6)	(20)	(6)
Credit losses	(21)	(1)	(21)	(1)
Other impairments	(61)	0	(67)	(13)
Total	$ (86)	$ 498	$ (84)	$ 548

Investments - Available-for-S_2

Investments - Available-for-Sale Securities by Contractual Maturity (Details) - RiverSource Life - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Amortized Cost
Due within one year	$ 330
Due after one year through five years	1,675
Due after five years through 10 years	3,661
Due after 10 years	4,235
Total having single maturity dates	9,901
Amortized Cost	16,809	$ 14,718
Fair Value
Due within one year	328
Due after one year through five years	1,607
Due after five years through 10 years	3,085
Due after 10 years	4,054
Total having single maturity dates	9,074
Fair Value	15,389	16,239
Residential mortgage backed securities
Amortized Cost
Without single maturity dates	2,944
Amortized Cost	2,944	2,226
Fair Value
Without single maturity dates	2,625
Fair Value	2,625	2,250
Commercial mortgage backed securities
Amortized Cost
Without single maturity dates	3,056
Amortized Cost	3,056	2,615
Fair Value
Without single maturity dates	2,798
Fair Value	2,798	2,656
Asset backed securities
Amortized Cost
Without single maturity dates	908
Amortized Cost	908	517
Fair Value
Without single maturity dates	892
Fair Value	$ 892	$ 537

Investments - Summary of Net In

Investments - Summary of Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net investment income
Fixed maturities	$ 156	$ 137	$ 435	$ 511
Mortgage loans	18	21	55	82
Other investments	55	40	92	86
Gross investment income	229	198	582	679
Less: investment expenses	5	5	14	15
Total	$ 224	$ 193	$ 568	$ 664

Financing Receivables - Allowan

Financing Receivables - Allowance for Credit Losses - (Details) - Commercial Loans - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Rollforward of allowance for credit losses
Beginning balance	$ 12	$ 35
Provisions	(1)	(21)
Ending balance	11	$ 14
Accrued investment income
Financing Receivables
Accrued interest on loans	$ 12		$ 11

Financing Receivables - Purchas

Financing Receivables - Purchases, Sales and Nonperforming (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Nonperforming
Financing Receivables
Loans	$ 3		$ 3		$ 0
Deteriorated credit quality
Financing Receivables
Loans purchased			0
Commercial Loans | Commercial Loan
Financing Receivables
Loans sold	0	$ 746	0	$ 746
Commercial Loans | Syndicated loans
Financing Receivables
Loans purchased	0	0	42	26
Loans sold	0	$ 350	0	$ 354
Loans	$ 76		$ 76		$ 43

Financing Receivables - General

Financing Receivables - General Credit Quality Information - Commercial Mortgage Loans (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Commercial Loans | Commercial mortgage loans
Financing Receivables
Loans	$ 1,815	$ 1,800
Commercial Loans | Commercial mortgage loans | Past due
Financing Receivables
Loans	$ 3	$ 0
Total commercial mortgage loans | Credit concentration risk | Commercial Loans | Commercial mortgage loans
Financing Receivables
Percentage of total	100%	100%
Total commercial mortgage loans | Credit concentration risk | Highest credit risk rating | Maximum
Financing Receivables
Percentage of total	1%	1%

Financing Receivables - Credit

Financing Receivables - Credit Quality - Commercial Mortgage Loans by LTV Ratio and Year of Origination (Details) - Commercial Loans - Commercial mortgage loans - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	$ 91	$ 193
Year 2	188	116
Year 3	113	209
Year 4	197	101
Year 5	151	154
Prior	1,075	1,027
Total amortized cost basis	1,815	1,800
Greater than 100 Percent
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	0	0
Year 2	0	0
Year 3	2	20
Year 4	2	10
Year 5	0	0
Prior	39	29
Total amortized cost basis	43	59
80 to 100 Percent
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	1	9
Year 2	9	2
Year 3	2	9
Year 4	20	2
Year 5	8	0
Prior	47	29
Total amortized cost basis	87	51
60 to 80 Percent
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	35	141
Year 2	87	76
Year 3	17	59
Year 4	52	15
Year 5	10	58
Prior	95	133
Total amortized cost basis	296	482
40 to 60 Percent
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	40	37
Year 2	84	30
Year 3	65	75
Year 4	80	74
Year 5	55	49
Prior	432	393
Total amortized cost basis	756	658
Less than 40 Percent
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	15	6
Year 2	8	8
Year 3	27	46
Year 4	43	0
Year 5	78	47
Prior	462	443
Total amortized cost basis	$ 633	$ 550

Financing Receivables - Credi_2

Financing Receivables - Credit Quality - Commercial Mortgage Loans by Region (Details) - Commercial Loans - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Financing receivables - credit quality information
Less: allowance for credit losses	$ 11	$ 12	$ 14	$ 35
Commercial mortgage loans
Financing receivables - credit quality information
Loans	1,815	1,800
Less: allowance for credit losses	11	12
Total loans	1,804	1,788
Commercial mortgage loans | East North Central
Financing receivables - credit quality information
Loans	199	183
Commercial mortgage loans | East South Central
Financing receivables - credit quality information
Loans	52	54
Commercial mortgage loans | Middle Atlantic
Financing receivables - credit quality information
Loans	95	107
Commercial mortgage loans | Mountain
Financing receivables - credit quality information
Loans	122	111
Commercial mortgage loans | New England
Financing receivables - credit quality information
Loans	17	21
Commercial mortgage loans | Pacific
Financing receivables - credit quality information
Loans	603	589
Commercial mortgage loans | South Atlantic
Financing receivables - credit quality information
Loans	484	477
Commercial mortgage loans | West North Central
Financing receivables - credit quality information
Loans	127	136
Commercial mortgage loans | West South Central
Financing receivables - credit quality information
Loans	$ 116	$ 122
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans
Financing receivables - credit quality information
Percentage of total	100%	100%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | East North Central
Financing receivables - credit quality information
Percentage of total	11%	10%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | East South Central
Financing receivables - credit quality information
Percentage of total	3%	3%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Middle Atlantic
Financing receivables - credit quality information
Percentage of total	5%	6%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Mountain
Financing receivables - credit quality information
Percentage of total	7%	6%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | New England
Financing receivables - credit quality information
Percentage of total	1%	1%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Pacific
Financing receivables - credit quality information
Percentage of total	33%	33%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | South Atlantic
Financing receivables - credit quality information
Percentage of total	27%	26%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | West North Central
Financing receivables - credit quality information
Percentage of total	7%	8%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | West South Central
Financing receivables - credit quality information
Percentage of total	6%	7%

Financing Receivables - Credi_3

Financing Receivables - Credit Quality - Commercial Mortgage Loans by Property Type (Details) - Commercial Loans - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Financing receivables - credit quality information
Less: allowance for credit losses	$ 11	$ 12	$ 14	$ 35
Commercial mortgage loans
Financing receivables - credit quality information
Loans	1,815	1,800
Less: allowance for credit losses	11	12
Total loans	1,804	1,788
Commercial mortgage loans | Apartments
Financing receivables - credit quality information
Loans	479	464
Commercial mortgage loans | Hotel
Financing receivables - credit quality information
Loans	14	15
Commercial mortgage loans | Industrial
Financing receivables - credit quality information
Loans	292	293
Commercial mortgage loans | Mixed use
Financing receivables - credit quality information
Loans	55	57
Commercial mortgage loans | Office
Financing receivables - credit quality information
Loans	250	254
Commercial mortgage loans | Retail
Financing receivables - credit quality information
Loans	593	589
Commercial mortgage loans | Other
Financing receivables - credit quality information
Loans	$ 132	$ 128
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans
Financing receivables - credit quality information
Percentage of total	100%	100%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Apartments
Financing receivables - credit quality information
Percentage of total	26%	26%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Hotel
Financing receivables - credit quality information
Percentage of total	1%	1%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Industrial
Financing receivables - credit quality information
Percentage of total	16%	16%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Mixed use
Financing receivables - credit quality information
Percentage of total	3%	3%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Office
Financing receivables - credit quality information
Percentage of total	14%	14%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Retail
Financing receivables - credit quality information
Percentage of total	33%	33%
Total commercial mortgage loans | Credit concentration risk | Commercial mortgage loans | Other
Financing receivables - credit quality information
Percentage of total	7%	7%

Financing Receivables - Credi_4

Financing Receivables - Credit Quality Information - Syndicated Loans (Details) - Commercial Loans - Syndicated loans - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	$ 6	$ 15
Year 2	23	0
Year 3	3	4
Year 4	11	4
Year 5	5	11
Prior	28	9
Total amortized cost basis	76	43
Risk 5
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	0	0
Year 2	0	0
Year 3	0	0
Year 4	0	0
Year 5	0	0
Prior	0	0
Total amortized cost basis	0	0
Risk 4
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	0	0
Year 2	0	0
Year 3	0	0
Year 4	0	0
Year 5	0	0
Prior	0	0
Total amortized cost basis	0	0
Risk 3
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	0	0
Year 2	5	0
Year 3	0	0
Year 4	3	0
Year 5	0	0
Prior	2	1
Total amortized cost basis	10	1
Risk 2
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	5	11
Year 2	13	0
Year 3	2	4
Year 4	5	1
Year 5	0	8
Prior	15	4
Total amortized cost basis	40	28
Risk 1
Amortized cost basis by year of origination and loan-to-value ratio
Year 1	1	4
Year 2	5	0
Year 3	1	0
Year 4	3	3
Year 5	5	3
Prior	11	4
Total amortized cost basis	26	14
Past due
Amortized cost basis by year of origination and loan-to-value ratio
Total amortized cost basis	$ 0	$ 0

Financing Receivables -Credit Q

Financing Receivables -Credit Quality Information - Policy Loans and Deposit Receivable (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Receivable
Reinsurance deposit receivable	$ 7,500	$ 7,900
Deposit Receivable
Receivable
Allowance for credit losses	0	0
Consumer | Policy Loans
Financing Receivables
Allowance for credit losses	$ 0	$ 0

Financing Receivables - Trouble

Financing Receivables - Troubled Debt Restructurings (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) loan	Sep. 30, 2021 loan	Sep. 30, 2022 USD ($) loan	Sep. 30, 2021 loan
Troubled Debt Restructurings
Loans accounted for as troubled debt restructuring | loan	0	0	0	0
Commitments to lend additional funds to borrowers whose loans have been restructured | $	$ 0		$ 0

Deferred Acquisition Costs an_3

Deferred Acquisition Costs and Deferred Sales Inducement Costs (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Deferred Charges, Insurers [Abstract]
Increase (decrease) from surrenders	$ 49	$ 49
Increase (decrease) from updating morality assumptions	(27)	(27)
Increase (decrease) from updating discount rate	(13)	(13)
Balances of and changes in DAC
Beginning balance		2,757	$ 2,508
Capitalization of acquisition costs		146	196
Amortization		(351)	(129)
Amortization, impact of valuation assumptions review		8	60
Impact of change in net unrealized (gains) losses on securities		420	75
Ending balance	2,980	2,980	2,710
Balances of and changes in DSIC
Beginning balance		187	187
Capitalization of sales inducement costs		1	1
Amortization		(34)	(15)
Amortization, impact of valuation assumptions review		2	2
Impact of change in net unrealized (gains) losses on securities		15	11
Ending balance	$ 171	$ 171	$ 186

Policyholder Account Balances_3

Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities - Balances by Product (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Policyholder account balances, future policy benefits and claims
Policyholder account balances	$ 24,224	$ 23,747
Future policy benefits	11,037	11,752
Policy claims and other policyholders’ funds	214	245
Policyholder account balances, future policy benefits and claims	35,475	35,744
Fixed annuities
Policyholder account balances, future policy benefits and claims
Policyholder account balances	7,776	8,117
Variable annuity fixed sub-accounts
Policyholder account balances, future policy benefits and claims
Policyholder account balances	4,887	4,990
UL/VUL insurance
Policyholder account balances, future policy benefits and claims
Policyholder account balances	3,069	3,103
IUL insurance
Policyholder account balances, future policy benefits and claims
Policyholder account balances	2,645	2,534
Structured variable annuities
Policyholder account balances, future policy benefits and claims
Policyholder account balances	5,314	4,440
Other life Insurance
Policyholder account balances, future policy benefits and claims
Policyholder account balances	533	563
Variable annuity GMWB
Policyholder account balances, future policy benefits and claims
Future policy benefits	2,101	2,336
Variable annuity GMAB
Policyholder account balances, future policy benefits and claims
Future policy benefits	64	(23)
Other annuity liabilities
Policyholder account balances, future policy benefits and claims
Future policy benefits	316	67
Fixed annuity life contingent liabilities
Policyholder account balances, future policy benefits and claims
Future policy benefits	1,215	1,278
Life and disability income insurance
Policyholder account balances, future policy benefits and claims
Future policy benefits	1,106	1,139
Long term care insurance
Policyholder account balances, future policy benefits and claims
Future policy benefits	5,187	5,664
UL/VUL and other life insurance additional liabilities
Policyholder account balances, future policy benefits and claims
Future policy benefits	$ 1,048	$ 1,291

Policyholder Account Balances_4

Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities - Components of Separate Account Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Separate account liabilities
Variable annuity	$ 61,063	$ 82,862
VUL insurance	7,090	9,343
Other insurance	24	33
Total	$ 68,177	$ 92,238

Variable Annuity and Insuranc_3

Variable Annuity and Insurance Guarantees - VA Guarantees (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
GMDB
Information related to variable annuity guarantees
Total contract value	$ 65,235	$ 87,246
Contract value in separate accounts	60,541	82,287
Net amount at risk	$ 3,126	$ 64
Weighted average attained age	69 years	69 years
GMDB | Return of premium
Information related to variable annuity guarantees
Total contract value	$ 51,949	$ 70,020
Contract value in separate accounts	50,290	68,145
Net amount at risk	$ 1,440	$ 6
Weighted average attained age	69 years	69 years
GMDB | Five/six-year reset
Information related to variable annuity guarantees
Total contract value	$ 6,652	$ 8,309
Contract value in separate accounts	3,986	5,612
Net amount at risk	$ 277	$ 6
Weighted average attained age	69 years	68 years
GMDB | One-year ratchet
Information related to variable annuity guarantees
Total contract value	$ 4,612	$ 6,177
Contract value in separate accounts	4,306	5,858
Net amount at risk	$ 1,019	$ 13
Weighted average attained age	72 years	71 years
GMDB | Five-year ratchet
Information related to variable annuity guarantees
Total contract value	$ 1,058	$ 1,438
Contract value in separate accounts	1,009	1,386
Net amount at risk	$ 106	$ 1
Weighted average attained age	68 years	68 years
GMDB | Other
Information related to variable annuity guarantees
Total contract value	$ 964	$ 1,302
Contract value in separate accounts	950	1,286
Net amount at risk	$ 284	$ 38
Weighted average attained age	75 years	74 years
GGU death benefit
Information related to variable annuity guarantees
Total contract value	$ 966	$ 1,260
Contract value in separate accounts	909	1,198
Net amount at risk	$ 139	$ 184
Weighted average attained age	72 years	72 years
GMIB
Information related to variable annuity guarantees
Total contract value	$ 130	$ 184
Contract value in separate accounts	117	170
Net amount at risk	$ 14	$ 4
Weighted average attained age	72 years	71 years
GMWB
Information related to variable annuity guarantees
Total contract value	$ 39,222	$ 54,287
Contract value in separate accounts	39,211	54,229
Net amount at risk	$ 3,144	$ 188
Weighted average attained age	70 years	69 years
GMWB | GMWB standard benefit
Information related to variable annuity guarantees
Total contract value	$ 1,351	$ 1,900
Contract value in separate accounts	1,346	1,895
Net amount at risk	$ 54	$ 1
Weighted average attained age	75 years	75 years
GMWB | GMWB for life
Information related to variable annuity guarantees
Total contract value	$ 37,871	$ 52,387
Contract value in separate accounts	37,865	52,334
Net amount at risk	$ 3,090	$ 187
Weighted average attained age	70 years	69 years
GMAB
Information related to variable annuity guarantees
Total contract value	$ 1,391	$ 2,005
Contract value in separate accounts	1,391	2,005
Net amount at risk	$ 187	$ 0
Weighted average attained age	62 years	62 years

Variable Annuity and Insuranc_4

Variable Annuity and Insurance Guarantees - UL Secondary Guarantees (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
UL secondary guarantees
Insurance guarantees
Net amount at risk	$ 6,496	$ 6,564
Weighted average attained age	69 years	68 years
Structured variable annuity GMDB
Insurance guarantees
Net amount at risk	$ 723	$ 3
Weighted average attained age	64 years	63 years

Variable Annuity and Insuranc_5

Variable Annuity and Insurance Guarantees - Liability Rollforward (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
GMDB & GGU
Changes in additional liabilities for variable annuity and insurance guarantees
Beginning Balance	$ 36	$ 24
Incurred claims	40	12
Paid claims	(15)	(3)
Ending Balance	61	33
GMIB
Changes in additional liabilities for variable annuity and insurance guarantees
Beginning Balance	5	6
Incurred claims	2	1
Paid claims	0	(1)
Ending Balance	7	6
GMWB
Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees
Beginning balance	2,336	3,049
Incurred claims	(235)	(793)
Paid claims	0	0
Ending balance	2,101	2,256
GMAB
Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees
Beginning balance	(23)	1
Incurred claims	87	(15)
Paid claims	0	0
Ending balance	64	(14)
UL
Changes in additional liabilities for variable annuity and insurance guarantees
Beginning Balance	1,020	916
Incurred claims	87	106
Paid claims	(31)	(27)
Ending Balance	$ 1,076	$ 995

Variable Annuity and Insuranc_6

Variable Annuity and Insurance Guarantees - Separate Account Balances by Type (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Mutual funds
Variable Annuity and Insurance Guarantees
Total mutual funds	$ 65,830	$ 82,497
Equity
Variable Annuity and Insurance Guarantees
Total mutual funds	38,594	49,183
Bond
Variable Annuity and Insurance Guarantees
Total mutual funds	21,012	24,998
Other
Variable Annuity and Insurance Guarantees
Total mutual funds	$ 6,224	$ 8,316

Debt - Short-term Borrowings (D

Debt - Short-term Borrowings (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Short-term borrowings
Amount of FHLB liability	$ 201	$ 200
RiverSource Life
Short-term borrowings
Amount of FHLB liability	$ 201	$ 200
RiverSource Life | Weighted average
Short-term borrowings
Interest rate on FHLB borrowings (as a percent)	3.20%	0.30%
RiverSource Life | Commercial mortgage backed securities
Short-term borrowings
Securities pledged as collateral for FHLB borrowings	$ 1,300	$ 1,000
RiverSource Life | Federal Home Loan Bank borrowings | Maximum
Short-term borrowings
Term	3 months	3 months

Debt - Long-Term Debt (Details)

Debt - Long-Term Debt (Details) - Ameriprise Financial - Unsecured surplus note due December 31, 2050 - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt
Long-term debt	$ 500	$ 500
Interest rate (as a percent)	3.50%

Fair Values of Assets and Lia_3

Fair Values of Assets and Liabilities - Recurring Basis (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Assets
Separate account assets at NAV	$ 68,177	$ 92,238
GMWB and GMAB embedded derivatives
Assets
Receivables: embedded derivatives	224	133
Liabilities
Liabilities embedded derivatives	1,200	1,600
RiverSource Life
Assets
Total Available-for-Sale securities	15,389	16,239
RiverSource Life | Corporate debt securities
Assets
Total Available-for-Sale securities	8,240	9,638
RiverSource Life | Residential mortgage backed securities
Assets
Total Available-for-Sale securities	2,625	2,250
RiverSource Life | Commercial mortgage backed securities
Assets
Total Available-for-Sale securities	2,798	2,656
RiverSource Life | State and municipal obligations
Assets
Total Available-for-Sale securities	797	1,074
RiverSource Life | Asset backed securities
Assets
Total Available-for-Sale securities	892	537
RiverSource Life | Foreign government bonds and obligations
Assets
Total Available-for-Sale securities	36	83
RiverSource Life | U.S. government and agency obligations
Assets
Total Available-for-Sale securities	1	1
RiverSource Life | Policyholder account balances, future policy benefits and claims embedded derivatives
Liabilities
Cumulative increase (decrease) in embedded derivatives of adjustment for nonperformance risk	(778)	(598)
RiverSource Life | Level 3 | Corporate debt securities
Assets
Total Available-for-Sale securities	394	496
RiverSource Life | Level 3 | Asset backed securities
Assets
Total Available-for-Sale securities	556	291
RiverSource Life | Level 3 | Fixed deferred indexed annuities ceded embedded derivatives
Assets
Receivables: embedded derivatives	47	59
RiverSource Life | Level 3 | Fixed deferred indexed annuity embedded derivatives
Liabilities
Liabilities embedded derivatives, net	43	56
RiverSource Life | Level 3 | IUL embedded derivatives
Liabilities
Liabilities embedded derivatives, net	689	905
RiverSource Life | Level 3 | GMWB and GMAB embedded derivatives
Liabilities
Liabilities embedded derivatives, net	932	1,486
RiverSource Life | Level 3 | Structured variable annuity embedded derivatives
Liabilities
Liabilities embedded derivatives, net	(513)	406
RiverSource Life | Recurring basis
Assets
Total Available-for-Sale securities	15,389	16,239
Cash equivalents	2,473	3,176
Other assets: derivative contracts	3,198	5,517
Separate account assets at NAV	68,177	92,238
Total assets at fair value	89,284	117,229
Liabilities
Other liabilities: derivative contracts	3,080	4,180
Total liabilities at fair value	4,234	7,038
RiverSource Life | Recurring basis | Corporate debt securities
Assets
Total Available-for-Sale securities	8,240	9,638
RiverSource Life | Recurring basis | Residential mortgage backed securities
Assets
Total Available-for-Sale securities	2,625	2,250
RiverSource Life | Recurring basis | Commercial mortgage backed securities
Assets
Total Available-for-Sale securities	2,798	2,656
RiverSource Life | Recurring basis | State and municipal obligations
Assets
Total Available-for-Sale securities	797	1,074
RiverSource Life | Recurring basis | Asset backed securities
Assets
Total Available-for-Sale securities	892	537
RiverSource Life | Recurring basis | Foreign government bonds and obligations
Assets
Total Available-for-Sale securities	36	83
RiverSource Life | Recurring basis | U.S. government and agency obligations
Assets
Total Available-for-Sale securities	1	1
RiverSource Life | Recurring basis | Fixed deferred indexed annuities ceded embedded derivatives
Assets
Receivables: embedded derivatives	47	59
RiverSource Life | Recurring basis | Policyholder account balances, future policy benefits and claims embedded derivatives
Liabilities
Liabilities embedded derivatives, net	1,154	2,858
RiverSource Life | Recurring basis | Fixed deferred indexed annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	46	61
RiverSource Life | Recurring basis | IUL embedded derivatives
Liabilities
Liabilities embedded derivatives	689	905
RiverSource Life | Recurring basis | GMWB and GMAB embedded derivatives
Liabilities
Liabilities embedded derivatives, net	932	1,486
RiverSource Life | Recurring basis | Structured variable annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	(513)	406
RiverSource Life | Recurring basis | Interest rate derivative contracts
Assets
Other assets: derivative contracts	377	1,252
Liabilities
Other liabilities: derivative contracts	585	468
RiverSource Life | Recurring basis | Equity derivative contracts
Assets
Other assets: derivative contracts	2,656	4,238
Liabilities
Other liabilities: derivative contracts	2,481	3,711
RiverSource Life | Recurring basis | Foreign exchange derivative contracts
Assets
Other assets: derivative contracts	89	18
Liabilities
Other liabilities: derivative contracts	14	1
RiverSource Life | Recurring basis | Credit derivative contracts
Assets
Other assets: derivative contracts	76	9
RiverSource Life | Recurring basis | Level 1
Assets
Total Available-for-Sale securities	1	1
Cash equivalents	1,155	1,985
Other assets: derivative contracts	153	160
Total assets at fair value	1,309	2,146
Liabilities
Other liabilities: derivative contracts	158	103
Total liabilities at fair value	158	103
RiverSource Life | Recurring basis | Level 1 | Corporate debt securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | Residential mortgage backed securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | Commercial mortgage backed securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | State and municipal obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | Asset backed securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | Foreign government bonds and obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 1 | U.S. government and agency obligations
Assets
Total Available-for-Sale securities	1	1
RiverSource Life | Recurring basis | Level 1 | Fixed deferred indexed annuities ceded embedded derivatives
Assets
Receivables: embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 1 | Policyholder account balances, future policy benefits and claims embedded derivatives
Liabilities
Liabilities embedded derivatives, net	0	0
RiverSource Life | Recurring basis | Level 1 | Fixed deferred indexed annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 1 | IUL embedded derivatives
Liabilities
Liabilities embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 1 | GMWB and GMAB embedded derivatives
Liabilities
Liabilities embedded derivatives, net	0	0
RiverSource Life | Recurring basis | Level 1 | Structured variable annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 1 | Interest rate derivative contracts
Assets
Other assets: derivative contracts	15	1
Liabilities
Other liabilities: derivative contracts	3	1
RiverSource Life | Recurring basis | Level 1 | Equity derivative contracts
Assets
Other assets: derivative contracts	137	158
Liabilities
Other liabilities: derivative contracts	153	101
RiverSource Life | Recurring basis | Level 1 | Foreign exchange derivative contracts
Assets
Other assets: derivative contracts	1	1
Liabilities
Other liabilities: derivative contracts	2	1
RiverSource Life | Recurring basis | Level 1 | Credit derivative contracts
Assets
Other assets: derivative contracts	0	0
RiverSource Life | Recurring basis | Level 2
Assets
Total Available-for-Sale securities	14,438	15,451
Cash equivalents	1,318	1,191
Other assets: derivative contracts	3,045	5,357
Total assets at fair value	18,801	21,999
Liabilities
Other liabilities: derivative contracts	2,922	4,077
Total liabilities at fair value	2,925	4,082
RiverSource Life | Recurring basis | Level 2 | Corporate debt securities
Assets
Total Available-for-Sale securities	7,846	9,142
RiverSource Life | Recurring basis | Level 2 | Residential mortgage backed securities
Assets
Total Available-for-Sale securities	2,625	2,250
RiverSource Life | Recurring basis | Level 2 | Commercial mortgage backed securities
Assets
Total Available-for-Sale securities	2,798	2,656
RiverSource Life | Recurring basis | Level 2 | State and municipal obligations
Assets
Total Available-for-Sale securities	797	1,074
RiverSource Life | Recurring basis | Level 2 | Asset backed securities
Assets
Total Available-for-Sale securities	336	246
RiverSource Life | Recurring basis | Level 2 | Foreign government bonds and obligations
Assets
Total Available-for-Sale securities	36	83
RiverSource Life | Recurring basis | Level 2 | U.S. government and agency obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 2 | Fixed deferred indexed annuities ceded embedded derivatives
Assets
Receivables: embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 2 | Policyholder account balances, future policy benefits and claims embedded derivatives
Liabilities
Liabilities embedded derivatives, net	3	5
RiverSource Life | Recurring basis | Level 2 | Fixed deferred indexed annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	3	5
RiverSource Life | Recurring basis | Level 2 | IUL embedded derivatives
Liabilities
Liabilities embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 2 | GMWB and GMAB embedded derivatives
Liabilities
Liabilities embedded derivatives, net	0	0
RiverSource Life | Recurring basis | Level 2 | Structured variable annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	0	0
RiverSource Life | Recurring basis | Level 2 | Interest rate derivative contracts
Assets
Other assets: derivative contracts	362	1,251
Liabilities
Other liabilities: derivative contracts	582	467
RiverSource Life | Recurring basis | Level 2 | Equity derivative contracts
Assets
Other assets: derivative contracts	2,519	4,080
Liabilities
Other liabilities: derivative contracts	2,328	3,610
RiverSource Life | Recurring basis | Level 2 | Foreign exchange derivative contracts
Assets
Other assets: derivative contracts	88	17
Liabilities
Other liabilities: derivative contracts	12	0
RiverSource Life | Recurring basis | Level 2 | Credit derivative contracts
Assets
Other assets: derivative contracts	76	9
RiverSource Life | Recurring basis | Level 3
Assets
Total Available-for-Sale securities	950	787
Cash equivalents	0	0
Other assets: derivative contracts	0	0
Total assets at fair value	997	846
Liabilities
Other liabilities: derivative contracts	0	0
Total liabilities at fair value	1,151	2,853
RiverSource Life | Recurring basis | Level 3 | Corporate debt securities
Assets
Total Available-for-Sale securities	394	496
RiverSource Life | Recurring basis | Level 3 | Residential mortgage backed securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 3 | Commercial mortgage backed securities
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 3 | State and municipal obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 3 | Asset backed securities
Assets
Total Available-for-Sale securities	556	291
RiverSource Life | Recurring basis | Level 3 | Foreign government bonds and obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 3 | U.S. government and agency obligations
Assets
Total Available-for-Sale securities	0	0
RiverSource Life | Recurring basis | Level 3 | Fixed deferred indexed annuities ceded embedded derivatives
Assets
Receivables: embedded derivatives	47	59
RiverSource Life | Recurring basis | Level 3 | Policyholder account balances, future policy benefits and claims embedded derivatives
Liabilities
Liabilities embedded derivatives, net	1,151	2,853
RiverSource Life | Recurring basis | Level 3 | Fixed deferred indexed annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	43	56
RiverSource Life | Recurring basis | Level 3 | IUL embedded derivatives
Liabilities
Liabilities embedded derivatives	689	905
RiverSource Life | Recurring basis | Level 3 | GMWB and GMAB embedded derivatives
Liabilities
Liabilities embedded derivatives, net	932	1,486
RiverSource Life | Recurring basis | Level 3 | Structured variable annuity embedded derivatives
Liabilities
Liabilities embedded derivatives	(513)	406
RiverSource Life | Recurring basis | Level 3 | Interest rate derivative contracts
Assets
Other assets: derivative contracts	0	0
Liabilities
Other liabilities: derivative contracts	0	0
RiverSource Life | Recurring basis | Level 3 | Equity derivative contracts
Assets
Other assets: derivative contracts	0	0
Liabilities
Other liabilities: derivative contracts	0	0
RiverSource Life | Recurring basis | Level 3 | Foreign exchange derivative contracts
Assets
Other assets: derivative contracts	0	0
Liabilities
Other liabilities: derivative contracts	0	0
RiverSource Life | Recurring basis | Level 3 | Credit derivative contracts
Assets
Other assets: derivative contracts	$ 0	$ 0

Fair Values of Assets and Lia_4

Fair Values of Assets and Liabilities - Changes in Level 3 Assets (Details) - RiverSource Life - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Available-for-Sale Securities
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	$ 694	$ 721	$ 787	$ 1,170
Total gains (losses) included in net income	0	(1)	(1)	(1)
Total gains (losses) included in other comprehensive income (loss)	(16)	(3)	(60)	(3)
Purchases	570	9	623	76
Issues		0		0
Settlements	(298)	(64)	(369)	(131)
Transfers into level 3		170		170
Transfers out of Level 3			(30)	(449)
Balance, ending	950	832	950	832
Changes in unrealized gains (losses) in net income relating to assets held at end of period			(1)
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period	(23)	(4)	(55)	(1)
Corporate debt securities
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	458	385	496	766
Total gains (losses) included in net income	0	(1)	(1)	(1)
Total gains (losses) included in other comprehensive income (loss)	(13)	(3)	(46)	(6)
Purchases	6	9	29	76
Issues		0		0
Settlements	(57)	(44)	(84)	(73)
Transfers into level 3		168		168
Transfers out of Level 3			0	(416)
Balance, ending	394	514	394	514
Changes in unrealized gains (losses) in net income relating to assets held at end of period			(1)
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period	(13)	(4)	(45)
Commercial mortgage backed securities
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning			0
Total gains (losses) included in net income			0
Total gains (losses) included in other comprehensive income (loss)			0
Purchases			30
Settlements			0
Transfers out of Level 3			(30)
Balance, ending	0		0
Changes in unrealized gains (losses) in net income relating to assets held at end of period			0
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period			0
Residential mortgage backed securities
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning				9
Total gains (losses) included in net income				0
Total gains (losses) included in other comprehensive income (loss)				0
Purchases				0
Issues				0
Settlements				0
Transfers into level 3				0
Transfers out of Level 3				(9)
Balance, ending		0		0
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period				0
Asset backed securities
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	236	336	291	395
Total gains (losses) included in net income	0	0	0	0
Total gains (losses) included in other comprehensive income (loss)	(3)	0	(14)	3
Purchases	564	0	564	0
Issues		0		0
Settlements	(241)	(20)	(285)	(58)
Transfers into level 3		2		2
Transfers out of Level 3			0	(24)
Balance, ending	556	318	556	318
Changes in unrealized gains (losses) in net income relating to assets held at end of period			0
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period	(10)	0	(10)	3
Fixed deferred indexed annuities ceded embedded derivatives
Summary of changes in Level 3 assets measured at fair value on a recurring basis
Balance, beginning	49	0	59
Total gains (losses) included in net income	(2)		(10)	0
Total gains (losses) included in other comprehensive income (loss)	0	0	0
Purchases	0	0	0
Issues		57
Settlements	0	(1)	(2)
Transfers into level 3		0
Transfers out of Level 3			0	0
Balance, ending	47	56	47	$ 56
Changes in unrealized gains (losses) in net income relating to assets held at end of period			0
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at end of period	$ 0	$ 0	$ 0

Fair Values of Assets and Lia_5

Fair Values of Assets and Liabilities - Changes in Level 3 Liabilities (Details) - RiverSource Life - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning		$ 2,569		$ 3,370
Total (gains) losses included in net income		(37)		(1,023)
Issues		88		256
Settlements		4		21
Balance, ending		2,624		2,624
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period		(46)		(1,185)
Net increase (decrease) to pretax income from adjustment for nonperformance risk on fair value of embedded derivatives	$ (37)	1	$ 182	(138)
Policyholder account balances, future policy benefits and claims embedded derivatives
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning	1,408		2,853
Total (gains) losses included in net income	(348)		(1,838)
Issues	126		323
Settlements	(35)		(187)
Balance, ending	1,151		1,151
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period	(341)		(1,810)
Fixed deferred indexed annuity embedded derivatives
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning	45	54	56	49
Total (gains) losses included in net income	(1)	1	(10)	7
Issues	0	0	0	0
Settlements	(1)	(1)	(3)	(2)
Balance, ending	43	54	43	54
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period	0	0	0	0
IUL embedded derivatives
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning	719	928	905	935
Total (gains) losses included in net income	(22)	14	(162)	51
Issues	18	0	26	4
Settlements	(26)	(25)	(80)	(73)
Balance, ending	689	917	689	917
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period	(22)	14	(162)	51
GMWB and GMAB embedded derivatives
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning	1,006	1,373	1,486	2,316
Total (gains) losses included in net income	(152)	(69)	(727)	(1,273)
Issues	89	95	260	274
Settlements	(11)	37	(87)	119
Balance, ending	932	1,436	932	1,436
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period	(146)	(60)	(709)	(1,236)
Structured variable annuity embedded derivatives
Changes in Level 3 liabilities measured at fair value on a recurring basis
Balance, beginning	(362)	214	406	70
Total (gains) losses included in net income	(173)	17	(939)	192
Issues	19	(7)	37	(22)
Settlements	3	(7)	(17)	(23)
Balance, ending	(513)	217	(513)	217
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period	$ (173)	$ 0	$ (939)	$ 0

Fair Values of Assets and Lia_6

Fair Values of Assets and Liabilities - Significant Unobservable inputs (Details) - RiverSource Life $ in Millions	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Significant unobservable inputs used in fair value measurements
Total Available-for-Sale securities	$ 15,389	$ 16,239
Corporate debt securities
Significant unobservable inputs used in fair value measurements
Total Available-for-Sale securities	8,240	9,638
Asset backed securities
Significant unobservable inputs used in fair value measurements
Total Available-for-Sale securities	892	537
Level 3 | Corporate debt securities
Significant unobservable inputs used in fair value measurements
Total Available-for-Sale securities	394	496
Level 3 | Asset backed securities
Significant unobservable inputs used in fair value measurements
Total Available-for-Sale securities	556	291
Level 3 | Fixed deferred indexed annuities ceded embedded derivatives
Significant unobservable inputs used in fair value measurements
Receivables: embedded derivatives	47	59
Level 3 | IUL embedded derivatives
Significant unobservable inputs used in fair value measurements
Liabilities embedded derivatives, net	689	905
Level 3 | Fixed deferred indexed annuity embedded derivatives
Significant unobservable inputs used in fair value measurements
Liabilities embedded derivatives, net	43	56
Level 3 | GMWB and GMAB embedded derivatives
Significant unobservable inputs used in fair value measurements
Liabilities embedded derivatives, net	932	1,486
Level 3 | Structured variable annuity embedded derivatives
Significant unobservable inputs used in fair value measurements
Liabilities embedded derivatives, net	$ (513)	$ 406
Level 3 | Discounted cash flow | Corporate debt securities | Minimum | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.010	0.008
Level 3 | Discounted cash flow | Corporate debt securities | Maximum | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.036	0.024
Level 3 | Discounted cash flow | Corporate debt securities | Weighted average | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.015	0.011
Level 3 | Discounted cash flow | Asset backed securities | Annual default rate
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.026	0.058
Level 3 | Discounted cash flow | Asset backed securities | Loss severity
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.250	0.250
Level 3 | Discounted cash flow | Asset backed securities | Minimum | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.0270
Level 3 | Discounted cash flow | Asset backed securities | Minimum | Yield/spread to swap rates
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs		0.0175
Level 3 | Discounted cash flow | Asset backed securities | Maximum | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.0450
Level 3 | Discounted cash flow | Asset backed securities | Maximum | Yield/spread to swap rates
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs		0.0275
Level 3 | Discounted cash flow | Asset backed securities | Weighted average | Yield/spread to U.S. Treasuries
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.0277
Level 3 | Discounted cash flow | Asset backed securities | Weighted average | Annual default rate
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.026	0.058
Level 3 | Discounted cash flow | Asset backed securities | Weighted average | Loss severity
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs	0.250	0.250
Level 3 | Discounted cash flow | Asset backed securities | Weighted average | Yield/spread to swap rates
Significant unobservable inputs used in fair value measurements
Fixed maturities, measurement inputs		0.0182
Level 3 | Discounted cash flow | Fixed deferred indexed annuities ceded embedded derivatives | Minimum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivative asset, measurement input	0	0
Level 3 | Discounted cash flow | Fixed deferred indexed annuities ceded embedded derivatives | Maximum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivative asset, measurement input	0.668	0.668
Level 3 | Discounted cash flow | Fixed deferred indexed annuities ceded embedded derivatives | Weighted average | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivative asset, measurement input	0.014	0.014
Level 3 | Discounted cash flow | IUL embedded derivatives | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | IUL embedded derivatives | Weighted average | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | Fixed deferred indexed annuity embedded derivatives | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | Fixed deferred indexed annuity embedded derivatives | Minimum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0	0
Level 3 | Discounted cash flow | Fixed deferred indexed annuity embedded derivatives | Maximum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.668	0.668
Level 3 | Discounted cash flow | Fixed deferred indexed annuity embedded derivatives | Weighted average | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.014	0.014
Level 3 | Discounted cash flow | Fixed deferred indexed annuity embedded derivatives | Weighted average | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Minimum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.001	0.001
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Minimum | Utilization of guaranteed withdrawals
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0	0
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Minimum | Market volatility
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.050	0.043
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Maximum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.557	0.557
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Maximum | Utilization of guaranteed withdrawals
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.480	0.480
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Maximum | Market volatility
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.175	0.168
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Weighted average | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.034	0.036
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Weighted average | Utilization of guaranteed withdrawals
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.109	0.106
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Weighted average | Market volatility
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.121	0.108
Level 3 | Discounted cash flow | GMWB and GMAB embedded derivatives | Weighted average | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | Structured variable annuity embedded derivatives | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065
Level 3 | Discounted cash flow | Structured variable annuity embedded derivatives | Minimum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.008	0.008
Level 3 | Discounted cash flow | Structured variable annuity embedded derivatives | Maximum | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.400	0.400
Level 3 | Discounted cash flow | Structured variable annuity embedded derivatives | Weighted average | Surrender rate
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.009	0.009
Level 3 | Discounted cash flow | Structured variable annuity embedded derivatives | Weighted average | Nonperformance risk
Significant unobservable inputs used in fair value measurements
Embedded derivatives, measurement inputs	0.0125	0.0065

Fair Values of Assets and Lia_7

Fair Values of Assets and Liabilities - Non-Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
VIEs, not primary beneficiary | Affordable Housing Partnerships and Other Real Estate Partnerships | Nonrecurring basis | Level 3
Assets and liabilities measured at fair value
Investment balance	$ 63	$ 93

Fair Values of Assets and Lia_8

Fair Values of Assets and Liabilities - Financial Instruments Not Reported at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financial Liabilities
Separate account liabilities - investment contracts	$ 68,177	$ 92,238
RiverSource Life
Financial Assets
Mortgage loans, net	1,804	1,788
Policy loans	838	834
Other investments	224	230
Receivables	7,794	8,148
Financial Liabilities
Long-term debt	500	500
Other liabilities	4,470	6,628
RiverSource Life | Carrying Value
Financial Assets
Mortgage loans, net	1,804	1,788
Policy loans	838	834
Other investments	94	61
Receivables	7,528	7,876
Financial Liabilities
Policyholder account balances, future policy benefits and claims	14,041	12,342
Short-term borrowings	201	200
Long-term debt	500	500
Other liabilities	8	9
RiverSource Life | Carrying Value | Investment contracts
Financial Liabilities
Separate account liabilities - investment contracts	288	403
RiverSource Life | Fair Value
Financial Assets
Mortgage loans, net	1,627	1,872
Policy loans	838	834
Other investments	93	61
Receivables	6,264	8,630
Financial Liabilities
Policyholder account balances, future policy benefits and claims	12,048	13,264
Short-term borrowings	201	200
Long-term debt	313	498
Other liabilities	7	9
RiverSource Life | Fair Value | Investment contracts
Financial Liabilities
Separate account liabilities - investment contracts	288	403
RiverSource Life | Fair Value | Level 1
Financial Assets
Mortgage loans, net	0	0
Policy loans	0	0
Other investments	0	0
Receivables	0	0
Financial Liabilities
Policyholder account balances, future policy benefits and claims	0	0
Short-term borrowings	0	0
Long-term debt	0	0
Other liabilities	0	0
RiverSource Life | Fair Value | Level 1 | Investment contracts
Financial Liabilities
Separate account liabilities - investment contracts	0	0
RiverSource Life | Fair Value | Level 2
Financial Assets
Mortgage loans, net	0	0
Policy loans	838	834
Other investments	72	40
Receivables	0	0
Financial Liabilities
Policyholder account balances, future policy benefits and claims	0	0
Short-term borrowings	201	200
Long-term debt	313	498
Other liabilities	0	0
RiverSource Life | Fair Value | Level 2 | Investment contracts
Financial Liabilities
Separate account liabilities - investment contracts	288	403
RiverSource Life | Fair Value | Level 3
Financial Assets
Mortgage loans, net	1,627	1,872
Policy loans	0	0
Other investments	21	21
Receivables	6,264	8,630
Financial Liabilities
Policyholder account balances, future policy benefits and claims	12,048	13,264
Short-term borrowings	0	0
Long-term debt	0	0
Other liabilities	7	9
RiverSource Life | Fair Value | Level 3 | Investment contracts
Financial Liabilities
Separate account liabilities - investment contracts	$ 0	$ 0

Offsetting Assets and Liabili_3

Offsetting Assets and Liabilities - Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivatives:
Gross Amounts of Recognized Assets	$ 3,198	$ 5,517
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Assets Presented in the Consolidated Balance Sheets	3,198	5,517
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(2,570)	(3,703)
Cash Collateral	(552)	(1,623)
Securities Collateral	(7)	(114)
Net amount	69	77
OTC
Derivatives:
Gross Amounts of Recognized Assets	2,975	5,330
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Assets Presented in the Consolidated Balance Sheets	2,975	5,330
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(2,386)	(3,571)
Cash Collateral	(552)	(1,623)
Securities Collateral	(7)	(114)
Net amount	30	22
OTC cleared
Derivatives:
Gross Amounts of Recognized Assets	105	88
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Assets Presented in the Consolidated Balance Sheets	105	88
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(105)	(41)
Cash Collateral	0	0
Securities Collateral	0	0
Net amount	0	47
Exchange-traded
Derivatives:
Gross Amounts of Recognized Assets	118	99
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Assets Presented in the Consolidated Balance Sheets	118	99
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(79)	(91)
Cash Collateral	0	0
Securities Collateral	0	0
Net amount	$ 39	$ 8

Offsetting Assets and Liabili_4

Offsetting Assets and Liabilities - Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivatives
Gross Amounts of Recognized Liabilities	$ 3,080	$ 4,180
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Liabilities Presented in the Consolidated Balance Sheets	3,080	4,180
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(2,570)	(3,703)
Cash Collateral	(70)	(181)
Securities Collateral	(331)	(293)
Net amount	109	3
OTC
Derivatives
Gross Amounts of Recognized Liabilities	2,791	4,048
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Liabilities Presented in the Consolidated Balance Sheets	2,791	4,048
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(2,386)	(3,571)
Cash Collateral	(70)	(181)
Securities Collateral	(322)	(293)
Net amount	13	3
OTC cleared
Derivatives
Gross Amounts of Recognized Liabilities	201	41
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Liabilities Presented in the Consolidated Balance Sheets	201	41
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(105)	(41)
Cash Collateral	0	0
Securities Collateral	0	0
Net amount	96	0
Exchange-traded
Derivatives
Gross Amounts of Recognized Liabilities	88	91
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Amounts of Liabilities Presented in the Consolidated Balance Sheets	88	91
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(79)	(91)
Cash Collateral	0	0
Securities Collateral	(9)	0
Net amount	$ 0	$ 0

Derivatives and Hedging Activ_3

Derivatives and Hedging Activities - Notional Value and Gross Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivatives and Hedging Activities
Notional	$ 167,311	$ 143,178
Gross Fair Value Assets, freestanding derivatives	3,198	5,517
Gross Fair Value Liabilities, freestanding derivatives	3,080	4,180
Total Gross Fair Value, derivative assets	3,245	5,576
Total Gross Fair Value, derivative liabilities	4,234	7,038
Derivative liability after application of master netting arrangements and cash collateral including embedded derivative liabilities	1,600	3,200
Fair value of investment securities received as collateral	7	123
Fair value of investment securities received as collateral that can be repledged	7	123
Fair value of investment securities received as collateral that were repledged	0	0
Policyholder account balances, future policy benefits and claims
Derivatives and Hedging Activities
Fair Value Liabilities, embedded derivatives, net	1,154	2,858
Receivables
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	47	59
GMWB and GMAB embedded derivatives
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	224	133
Embedded derivatives liability	1,200	1,600
GMWB and GMAB embedded derivatives | Policyholder account balances, future policy benefits and claims
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	0	0
Fair Value Liabilities, embedded derivatives, net	932	1,486
IUL embedded derivatives | Policyholder account balances, future policy benefits and claims
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	0	0
Embedded derivatives liability	689	905
Fixed deferred indexed annuity embedded derivatives | Policyholder account balances, future policy benefits and claims
Derivatives and Hedging Activities
Embedded derivatives liability	46	61
Fixed deferred indexed annuity embedded derivatives | Receivables
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	47	59
Structured variable annuity embedded derivatives | Policyholder account balances, future policy benefits and claims
Derivatives and Hedging Activities
Gross Fair Value Assets, embedded derivatives	0	0
Embedded derivatives liability	(513)	406
Not designated as hedging instruments
Derivatives and Hedging Activities
Notional	167,311	143,178
Not designated as hedging instruments | Other assets
Derivatives and Hedging Activities
Gross Fair Value Assets, freestanding derivatives	3,198	5,517
Not designated as hedging instruments | Other liabilities
Derivatives and Hedging Activities
Gross Fair Value Liabilities, freestanding derivatives	3,080	4,180
Not designated as hedging instruments | Interest rate contracts
Derivatives and Hedging Activities
Notional	95,693	79,459
Not designated as hedging instruments | Interest rate contracts | Other assets
Derivatives and Hedging Activities
Gross Fair Value Assets, freestanding derivatives	377	1,252
Not designated as hedging instruments | Interest rate contracts | Other liabilities
Derivatives and Hedging Activities
Gross Fair Value Liabilities, freestanding derivatives	585	468
Not designated as hedging instruments | Equity contracts
Derivatives and Hedging Activities
Notional	67,418	59,763
Not designated as hedging instruments | Equity contracts | Other assets
Derivatives and Hedging Activities
Gross Fair Value Assets, freestanding derivatives	2,656	4,238
Not designated as hedging instruments | Equity contracts | Other liabilities
Derivatives and Hedging Activities
Gross Fair Value Liabilities, freestanding derivatives	2,481	3,711
Not designated as hedging instruments | Credit contracts
Derivatives and Hedging Activities
Notional	1,684	1,717
Not designated as hedging instruments | Credit contracts | Other assets
Derivatives and Hedging Activities
Gross Fair Value Assets, freestanding derivatives	76	9
Not designated as hedging instruments | Credit contracts | Other liabilities
Derivatives and Hedging Activities
Gross Fair Value Liabilities, freestanding derivatives	0	0
Not designated as hedging instruments | Foreign exchange contracts
Derivatives and Hedging Activities
Notional	2,516	2,239
Not designated as hedging instruments | Foreign exchange contracts | Other assets
Derivatives and Hedging Activities
Gross Fair Value Assets, freestanding derivatives	89	18
Not designated as hedging instruments | Foreign exchange contracts | Other liabilities
Derivatives and Hedging Activities
Gross Fair Value Liabilities, freestanding derivatives	$ 14	$ 1

Derivatives and Hedging Activ_4

Derivatives and Hedging Activities - Derivatives Not Designated as Hedges Impact (Details) - Not designated as hedging instruments - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Investment Income
Impact of derivatives not designated as hedging instruments
Total gain (loss)	$ 0	$ 0	$ 0	$ 1
Net Investment Income | Interest rate contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Net Investment Income | Equity contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	1
Net Investment Income | Credit contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Net Investment Income | Foreign exchange contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0		0	0
Net Investment Income | GMWB and GMAB embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Net Investment Income | IUL embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Net Investment Income | Fixed deferred indexed annuity and deposit receivables embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)			0
Net Investment Income | Fixed deferred indexed annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)		0		0
Net Investment Income | Structured variable annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Interest Credited to Fixed Accounts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	25	12	110	70
Interest Credited to Fixed Accounts | Interest rate contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Interest Credited to Fixed Accounts | Equity contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	(23)	0	(135)	55
Interest Credited to Fixed Accounts | Credit contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Interest Credited to Fixed Accounts | Foreign exchange contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0		0	0
Interest Credited to Fixed Accounts | GMWB and GMAB embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Interest Credited to Fixed Accounts | IUL embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	48	11	242	22
Interest Credited to Fixed Accounts | Fixed deferred indexed annuity and deposit receivables embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)			3
Interest Credited to Fixed Accounts | Fixed deferred indexed annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)		1		(7)
Interest Credited to Fixed Accounts | Structured variable annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Benefits, Claims, Losses and Settlement Expenses
Impact of derivatives not designated as hedging instruments
Total gain (loss)	36	(249)	248	(1,004)
Benefits, Claims, Losses and Settlement Expenses | Interest rate contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	(753)	(171)	(2,815)	(1,125)
Benefits, Claims, Losses and Settlement Expenses | Equity contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	341	1	1,066	(613)
Benefits, Claims, Losses and Settlement Expenses | Credit contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	92	2	288	41
Benefits, Claims, Losses and Settlement Expenses | Foreign exchange contracts
Impact of derivatives not designated as hedging instruments
Total gain (loss)	112		219	6
Benefits, Claims, Losses and Settlement Expenses | GMWB and GMAB embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	71	(64)	551	879
Benefits, Claims, Losses and Settlement Expenses | IUL embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	0	0	0	0
Benefits, Claims, Losses and Settlement Expenses | Fixed deferred indexed annuity and deposit receivables embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)			0
Benefits, Claims, Losses and Settlement Expenses | Fixed deferred indexed annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)		0		0
Benefits, Claims, Losses and Settlement Expenses | Structured variable annuity embedded derivatives
Impact of derivatives not designated as hedging instruments
Total gain (loss)	$ 173	$ (17)	$ 939	$ (192)

Derivatives and Hedging Activ_5

Derivatives and Hedging Activities - Deferred Premium, Options and Swaptions (Details) - Options and swaptions $ in Millions	Sep. 30, 2022 USD ($)
Premiums payable
2022	$ 37
2023	50
2024	130
2025	118
2026	249
2027 - 2029	77
Total	661
Premiums Receivable
2022	62
2023	43
2024	23
2025	20
2026	88
2027 - 2029	0
Total	$ 236

Derivatives and Hedging Activ_6

Derivatives and Hedging Activities - Cash Flow Hedges and Credit Risk (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash Flow Hedges
Derivatives designated as cash flow hedges	$ 0	$ 0	$ 0	$ 0
Hedge relationships discontinued due to forecasted transactions no longer being expected to occur according to original hedge strategy	0	$ 0	0	$ 0
Credit Risk
Aggregate fair value of derivative contracts in net liability position containing credit contingent provisions	350		350		$ 383
Aggregate fair value of assets posted as collateral	338		338		383
Aggregate fair value of additional assets required to be posted or needed to settle	$ 12		$ 12		$ 0

Shareholder's Equity - OCI Comp

Shareholder's Equity - OCI Components (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Pretax
Total other comprehensive income (loss)	$ (537)	$ (408)	$ (1,775)	$ (660)
Income Tax Benefit (Expense)
Total other comprehensive income (loss)	113	87	381	141
Net of Tax
Arising during the period	(491)	73	(1,460)	(86)
Reclassification to net income	67	(394)	66	(433)
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Net Unrealized Gains (Losses) on Securities
Pretax
Total other comprehensive income (loss)	(537)	(408)	(1,775)	(660)
Income Tax Benefit (Expense)
Total other comprehensive income (loss)	113	87	381	141
Net of Tax
Arising during the period	(491)	73	(1,460)	(86)
Reclassification to net income	67	(394)	66	(433)
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Net unrealized gains (losses) on securities, excluding insurance related impact
Pretax
Arising during the period	(842)	(57)	(3,004)	(396)
Income Tax Benefit (Expense)
Arising during the period	178	14	639	86
Net of Tax
Arising during the period	(664)	(43)	(2,365)	(310)
Reclassification of net (gains) losses on securities included in net income
Pretax
Reclassification to net income	86	(498)	84	(548)
Income Tax Benefit (Expense)
Reclassification to net income	(19)	104	(18)	115
Net of Tax
Reclassification to net income	67	(394)	66	(433)
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables
Pretax
Arising during the period	219	147	1,145	284
Income Tax Benefit (Expense)
Arising during the period	(46)	(31)	(240)	(60)
Net of Tax
Arising during the period	$ 173	$ 116	$ 905	$ 224

Shareholder's Equity - Changes

Shareholder's Equity - Changes in AOCI Components (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Changes in balances of each component of AOCI, net of tax
Beginning balance	$ 1,059	$ 2,602	$ 1,885	$ 3,313
OCI before reclassifications	(491)	73	(1,460)	(86)
Amounts reclassified from AOCI	67	(394)	66	(433)
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Ending balance	586	1,959	586	1,959
Total AOCI
Changes in balances of each component of AOCI, net of tax
Beginning balance	(642)	722	328	920
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Ending balance	(1,066)	401	(1,066)	401
Net Unrealized Gains (Losses) on Securities
Changes in balances of each component of AOCI, net of tax
Beginning balance	(641)	723	329	921
OCI before reclassifications	(491)	73	(1,460)	(86)
Amounts reclassified from AOCI	67	(394)	66	(433)
Total other comprehensive income (loss), net of tax	(424)	(321)	(1,394)	(519)
Ending balance	(1,065)	402	(1,065)	402
Other
Changes in balances of each component of AOCI, net of tax
Beginning balance	(1)	(1)	(1)	(1)
OCI before reclassifications	0	0	0	0
Amounts reclassified from AOCI	0	0	0	0
Total other comprehensive income (loss), net of tax	0	0	0	0
Ending balance	$ (1)	$ (1)	$ (1)	$ (1)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income taxes
Effective tax rate (as a percent)	1.40%	15.60%	12.30%	12.70%
Valuation allowance	$ 11		$ 11		$ 11
Gross unrecognized tax benefits	37		37		37
Unrecognized tax benefits, net of federal tax benefits, that would affect the effective tax rate if recognized	20		20		20
Amount of decrease in unrecognized tax benefits reasonably possible within next 12 months	32		32
Interest and penalties recognized in income tax provision	0	$ 0	0	$ 0
Payable related to accrued interest and penalties	3		3		3
State deferred tax assets
Income taxes
Valuation allowance	2		2		2
State net operating losses
Income taxes
Valuation allowance	9		9		$ 9
State
Income taxes
Deferred tax assets, loss carryforwards	$ 9		$ 9

Contingencies (Details)

Contingencies (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Estimated liability related to guaranty fund assessments	$ 12	$ 12
Related premium tax asset	$ 10	$ 10